Proxy Statement (Form DEF 14A)
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.)
|
Filed by the Registrantx
|
|||||
|
Filed by a party other than the Registranto
|
|||||
|
Check the appropriate box:
|
|||||
|
o
|
Preliminary Proxy Statement | ||||
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||
|
x
|
Definitive Proxy Statement | ||||
|
o
|
Definitive Additional Materials | ||||
|
o
|
Soliciting Material under §240.14a-12 | ||||
|
|
|||||
|
(
|
|||||
|
(
|
|||||
|
Payment of Filing Fee (Check all boxes that apply):
|
|||||
|
x
|
No fee required. | ||||
|
o
|
Fee paid previously with preliminary materials. | ||||
|
o
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||||
Dear Stockholder:
You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the "Annual Meeting") of Ares Commercial Real Estate Corporation (the "Company") to be held on May 27, 2025 at 1:00 p.m. , EasteTime. The Annual Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast to enable our stockholders to participate from any location that is convenient to them. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ACRE2025.
At the Annual Meeting, you will be asked to (i) elect three director nominees to serve as Class I directors of the Company, (ii) ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm, (iii) approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers and (iv) recommend, on a non-binding, advisory basis, the frequency with which future stockholder advisory votes on the compensation of the Company's named executive officers will be held, each as more fully described in the accompanying proxy statement.
Your vote is important regardless of the number of shares you own.
We will be using the "Notice and Access" method of providing proxy materials to stockholders. We believe that this process will provide a convenient and quick way to access the proxy materials, including the Company's proxy statement and 2024 annual report to stockholders, and authorize a proxy to vote your shares, while allowing us to conserve natural resources and reduce the costs of printing and distributing the proxy materials.
On or about April 3, 2025 , the Company will mail to stockholders a Notice of Internet Availability of Proxy Materials, which we refer to as the Notice and Access card, containing instructions on how to access the proxy statement and 2024 annual report to stockholders and authorize a proxy to vote electronically via the Internet or by telephone. The Notice and Access card also contains instructions as to how stockholders can receive a paper copy of the proxy materials and authorize a proxy to vote by mail.
If you hold shares of the Company's common stock in "street name" through a broker, bank or other institution or nominee, you must follow the instructions provided by your broker or other financial institution regarding how to instruct your broker or financial institution to vote your shares.
We urge you to submit your proxy voting instructions to the Company as soon as possible even if you currently plan to attend the Annual Meeting. This will not prevent you from voting during the Annual Meeting, but will assure that your vote is counted if you are unable to attend the Annual Meeting.
On behalf of the board of directors, thank you for your continued interest and support.
| Sincerely, | |||||
|
/s/
|
|||||
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON MAY 27, 2025
To the Stockholders of Ares Commercial Real Estate Corporation :
Notice is hereby given that the 2025 Annual Meeting of Stockholders (the "Annual Meeting") of Ares Commercial Real Estate Corporation , a Maryland corporation (the "Company"), will be held on May 27, 2025 at 1:00 p.m. , EasteTime, for the following purposes:
1. To elect three director nominees to serve as Class I directors until the Company's 2028 annual meeting of stockholders, and until their successors are duly elected and qualify;
2. To consider and vote upon the ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 ;
3.To consider and vote upon a resolution to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the fiscal year endedDecember 31, 2024 , as described in the accompanying proxy statement;
4. To consider and recommend, on a non-binding, advisory basis, the frequency with which future votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers will be held; and
5. To consider and take action upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof.
The Annual Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast to enable our stockholders to participate from any location that is convenient to them. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ACRE2025. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting.
Only the holders of record of shares of common stock of the Company at the close of business on the record date, March 26, 2025 , will be entitled to receive notice of and vote at the Annual Meeting or any adjournment or postponement thereof. Such stockholders will be afforded the same rights and opportunities to vote, ask questions and participate as they would at an in-person annual meeting. In particular, such stockholders may submit questions live during the Annual Meeting by following the instructions and rules of conduct on the Annual Meeting website. During the Annual Meeting, the Company intends to answer questions that are pertinent to the Company and the official business of the Annual Meeting, subject to time constraints.
Stockholders are encouraged to enter the virtual Annual Meeting site prior to the start time in order to leave ample time to confirm the internet connection is sufficient to access the site and to allow sufficient time to log in and familiarize themselves with the virtual meeting platform. The virtual meeting platform is supported across different internet browsers and various devices (desktops, laptops, tablets, and smart phones) that have the most updated version of applicable software installed. Technical support will be available beginning 15 minutes prior to, and through the conclusion of, the Annual Meeting. For stockholders encountering any technical difficulties while accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available on the virtual meeting registration page 15 minutes prior to the start time of the meeting.
Your vote is important regardless of the number of shares you own. Accordingly, we urge you to promptly submit your proxy voting instructions even if you currently plan to attend the Annual Meeting. This will not prevent you from voting during the Annual Meeting, but will assure that your vote is counted if you are unable to attend the Annual Meeting.
You have the option to revoke your proxy at any time prior to the Annual Meeting, and to vote your shares personally if you attend the Annual Meeting. If there are not sufficient votes for a quorum or to approve or ratify any of the foregoing proposals at the time of the Annual Meeting, the meeting may be adjourned in order to permit further solicitation of proxies by the Company.
If you hold shares of the Company's common stock in "street name" through a broker, bank or other institution or nominee, you must follow the instructions provided by your broker or other financial institution regarding how to instruct your broker or financial institution to vote your shares.
Your proxy is being solicited on behalf of the Company's board of directors. The board of directors recommends that you vote FOR the election of the three director nominees listed in the accompanying proxy statement to serve as Class I directors until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualify, FOR the ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 ,FOR the resolution to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024 , and ONE YEAR with respect to the non-binding, advisory vote on the frequency of future votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
| By Order of the Board of Directors, | |||||
|
/s/
|
|||||
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May 27, 2025 :The proxy statement and the Company's 2024 annual report to stockholders are available at: http://materials.proxyvote.com/04013V.
PROXY STATEMENT FOR
2025 ANNUAL MEETING OF STOCKHOLDERS
This proxy statement is being furnished to stockholders in connection with the solicitation of proxies by the board of directors (the "Board") of Ares Commercial Real Estate Corporation , a Maryland corporation (the "Company," "we," "us" or "our"), for use at the Annual Meeting of Stockholders (the "Annual Meeting") to be held on May 27, 2025 at 1:00 p.m. , EasteTime, or at any adjournment or postponement thereof. This proxy statement, the notice of annual meeting of stockholders, related proxy card, and the 2024 annual report to stockholders are first being made available to our stockholders on or about April 3, 2025 .
The Annual Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast to enable our stockholders to participate from any location that is convenient to them. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ACRE2025.
This proxy statement is accompanied by our 2024 annual report, which includes audited financial statements for the fiscal year ended December 31, 2024 audited by Ernst & Young LLP , our independent registered public accounting firm, and their report thereon, dated February 11, 2025 .
We encourage you to vote your shares, either by voting in person at the Annual Meeting or by granting a proxy (i.e., authorizing someone to vote your shares). If you properly authorize your proxy and we receive it in time for the Annual Meeting, the persons named as proxies will vote the shares registered directly in your name in the manner that you specify.If you retuan executed proxy, but no specification is made, the votes entitled to be cast by you will be cast FOR the election of the three director nominees listed in the accompanying proxy statement to serve as Class I directors until our 2028 annual meeting of stockholders and until their successors are duly elected and qualify, FOR the ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 , FOR the resolution to approve, on a non-binding, advisory basis, the compensation of our named executive officers for the fiscal year ended December 31, 2024 and ONE YEAR with respect to the non-binding, advisory vote on the frequency of future votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. As to any other business which may properly come before the Annual Meeting or any postponements or adjournments thereof, the persons named as proxy holders on your proxy card will vote the shares of common stock represented by properly submitted proxies in their discretion.
Any stockholder "of record" (i.e., stockholders holding shares directly in their name) giving a valid proxy for the Annual Meeting may revoke it before it is exercised by giving a later dated properly executed proxy, by giving notice of revocation to us in writing before or at the Annual Meeting or by voting during the Annual Meeting. Stockholders holding shares in "street name" through a broker, bank or other institution or nominee, should contact their broker or other financial institution regarding how to revoke or change a valid proxy. You may vote your shares at the Annual Meeting by using the control number on your Notice and Access card, proxy card, or voting instruction form and following the instructions at www.virtualshareholdermeeting.com/ACRE2025. If you have already voted previously, there is no need to vote again at the Annual Meeting unless you wish to revoke and change your vote.
1
Unless revoked as stated above, the shares of common stock represented by valid proxies will be voted on all matters to be acted upon at the Annual Meeting. With respect to the election of directors, proxies cannot be voted for a greater number of persons than the number of nominees named.
The Board is not aware of any matter to be presented for action at the Annual Meeting other than the matters set forth herein. Should any other matter requiring a vote of stockholders arise, it is the intention of the persons named in the proxy to vote in accordance with their discretion on such matters. Stockholders have no dissenters' or appraisal rights in connection with any of the proposals described herein.
The record date for determination of stockholders entitled to vote at the Annual Meeting is the close of business on March 26, 2025 . As of the close of business on March 26, 2025 , there were 54,856,977 shares of our common stock outstanding. Each share of common stock has one vote. The presence, in person or by proxy at the Annual Meeting, of the holders of shares of common stock entitled to cast a majority of the votes entitled to be cast shall constitute a quorum for the purposes of the Annual Meeting. If there are insufficient votes for a quorum or to approve or ratify any of the foregoing proposals at the time of the Annual Meeting, the Chairman of the meeting may adjouthe Annual Meeting in order to permit further solicitation of proxies. Abstentions and broker non-votes will be deemed to be present for the purpose of determining a quorum for the Annual Meeting. A broker non-vote occurs when a nominee, broker or bank holding shares for a beneficial owner (i.e., a broker) does not vote on a particular proposal because such nominee, broker or bank does not have discretionary voting power for that particular matter and has not received instructions from the beneficial owner.
Under the rules of the New York Stock Exchange ("NYSE"), the only item to be acted upon at the Annual Meeting with respect to which a nominee, broker or bank will be permitted to exercise voting discretion is the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 . Therefore, if you hold your shares in "street name" and do not give the nominee, broker or bank specific voting instructions on the election of the three director nominees, the resolution to approve, on a non-binding, advisory basis, the compensation of our named executive officers for the fiscal year ended December 31, 2024 , or the vote to recommend, on a non-binding, advisory basis, the frequency with which future votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers will be held, your shares will not be voted on those items, and a broker non-vote will occur. Broker non-votes will have no effect on the voting results for such items.
The plurality of the votes cast at a meeting at which a quorum is present is required under our Second Amended and Restated Bylaws (the "Bylaws") to elect each of the three director nominees to serve as Class I directors until our 2028 annual meeting of stockholders and until their successors are duly elected and qualify. This means that the nominees with the most votes are elected. For purposes of the vote on Proposal 1, you may vote "For" or withhold authority to vote for each of the nominees to the Board. "Withheld" votes and broker non-votes will not be counted as votes cast and will have no effect on the result of the vote. However, each director has agreed that if he or she receives more "Withheld" votes than "For" votes, the director will tender his or her resignation for consideration by the nominating and governance committee. For additional details, including a description of our director majority vote resignation policy, see the section of this proxy statement entitled "Proposal 1: Election of Directors."
You may vote "For" or "Against," or abstain from voting on Proposal 2 to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm. The affirmative vote of at least a majority of all of the votes cast at a meeting at which a quorum is present is required for approval of Proposal 2 (meaning the number of shares voted "For" Proposal 2 must exceed the number of shares voted "Against" Proposal 2). For purposes of the vote on Proposal 2, abstentions will not be counted as votes cast and will have no effect on the result of the vote. There will not be broker non-votes with respect to Proposal 2.
You may vote "For" or "Against," or abstain from voting on Proposal 3 to approve, on a non-binding, advisory basis, the compensation of our named executive officers for the fiscal year endedDecember 31, 2024 . The affirmative vote of at least a majority of all of the votes cast at a meeting at which a quorum is present is required for approval of Proposal 3 (meaning the number of shares voted "For" Proposal 3 must exceed the number of shares voted "Against" Proposal 3). For purposes of the vote on Proposal 3, abstentions and broker non-votes will not be counted as votes cast and will have no effect on the result of the vote.
2
You may vote "One Year," "Two Years" or "Three Years," or abstain from voting on Proposal 4 to recommend, on a non-binding, advisory basis, the frequency with which votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers, will be held. The affirmative vote of at least a majority of all of the votes cast at a meeting at which a quorum is present is required for selection of the chosen frequency under Proposal 4 (meaning the number of shares voted for the preferred frequency under Proposal 4 must exceed the number of shares voted for the other choices under Proposal 4). However, if none of the frequency alternatives ("One Year," "Two Years" or "Three Years") receive a majority of the votes cast, we will consider the frequency with the highest number of votes cast by stockholders to be the frequency that has been selected by our stockholders. For purposes of the vote on Proposal 4, abstentions and broker non-votes will not be counted as votes cast and will have no effect on the result of the vote. The results of Proposal 4 will not be binding and we may decide that it is in the best interests of our stockholders and the Company to hold an advisory vote more or less frequently than the option approved.
We will bear the cost of solicitation of proxies in relation to this proxy statement. Proxies will be solicited by mail, by telephone, by electronic mail or by other electronic means or by requesting brokers and other custodians, nominees and fiduciaries to forward proxy soliciting material to the beneficial owners of shares of common stock held of record by such brokers, custodians, nominees and fiduciaries, each of whom we will reimburse for its expenses in so doing. In addition to the use of mail, directors, officers and regular employees of Ares Commercial Real Estate Management LLC , our external manager (our "Manager"), without special compensation therefor, may solicit proxies personally, by telephone, by electronic mail or by other electronic means from stockholders.
The Annual Meeting will be a completely virtual meeting of stockholders conducted exclusively via live audio webcast. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ACRE2025. To participate in the Annual Meeting, you will need the control number included on your Notice and Access card, proxy card, or voting instruction form. The Annual Meeting will begin promptly at 1:00 p.m. EasteTime on May 27, 2025 . We encourage you to access the virtual meeting website prior to the start time. You should allow ample time to ensure your ability to check-in and access the meeting. The virtual meeting platform is supported across different internet browsers and various devices (desktops, laptops, tablets, and smart phones) that have the most updated version of applicable software installed. If you encounter any difficulties while accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available on the virtual meeting registration page. Technical support will be available beginning 15 minutes prior to, and through the conclusion of, the Annual Meeting.
Stockholders of record as of the close of business on March 26, 2025 , the record date for the Annual Meeting, will be afforded the same rights and opportunities to vote, ask questions and participate as they would at an in-person annual meeting. We will hold a question and answer session with management immediately following the conclusion of the business to be conducted at the Annual Meeting. Stockholders may submit a question at any time during the meeting by visiting www.virtualshareholdermeeting.com/ACRE2025 and using the control number on your Notice and Access card, proxy card, or voting instruction form. During the Annual Meeting, we intend to answer questions that are pertinent to the Company and the official business of the Annual Meeting, subject to time constraints. The Chairman of the meeting has broad authority to conduct the Annual Meeting in an orderly manner, including establishing rules of conduct. A copy of the rules of conduct will be available online at the Annual Meeting.
The Board recommends that you vote FOR the election of the three director nominees listed in this proxy statement to serve as Class I directors until our 2028 annual meeting of stockholders and until their successors are duly elected and qualify, FOR the ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 , FORthe resolution to approve, on a non-binding, advisory basis, the compensation of our named executive officers for the fiscal year ended December 31, 2024 and ONE YEARwith respect to the non-binding, advisory vote on the frequency of future votes to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
3
PROPOSAL 1: ELECTION OF DIRECTORS
Election of Directors
Under our charter (as amended, the "Charter") and our Bylaws (as amended and restated, the "Bylaws"), our directors are divided into three classes. Directors are elected for a staggered term of three years each, with a term of office of only one of these three classes of directors expiring each year. Each director will hold office for the term to which he or she is elected and until his or her successor is duly elected and qualifies, or until the director's earlier resignation, death or removal.
The terms of William L. Browning , Edmond N. Moriarty , III and Rebecca J. Parekh , the Class I directors, will expire at the Annual Meeting. The nominating and governance committee has recommended, and the Board has nominated, Mr. Browning , Mr. Moriarty , and Ms. Parekh to stand for re-election at the Annual Meeting and to hold office until the annual meeting to be held in 2028 and until their successors are duly elected and qualify. Mr. Browning , Mr. Moriarty , and Ms. Parekh have agreed to serve as directors if elected and have consented to be named as nominees.
A stockholder can vote for or withhold his or her vote from each director nominee. Nominees are elected by a plurality of the votes cast at the Annual Meeting. This means that Mr. Browning , Mr. Moriarty and Ms. Parekh must receive the most votes to be elected as our directors for the term for which they have been nominated. However, pursuant to our Corporate Governance Guidelines, any nominee in an uncontested election who receives a greater number of votes withheld from his or her election than votes for his or her election will, within five days following the certification of the stockholder vote, tender his or her written resignation to the Chairman of the Board for consideration by the nominating and governance committee. An "uncontested election" is an election in which the number of nominees is not greater than the number of Board seats open for election. The nominating and governance committee will then review the director's continuation on the Board and recommend to the Board whether the Board should accept such tendered resignation. The Board, giving due consideration to the best interest of the Company and its stockholders, will evaluate the relevant facts and circumstances in connection with such director's resignation, and will make a decision, within 90 days following the certification of the stockholder vote, on whether to accept the tendered resignation. Any director who tenders a resignation pursuant to the director resignation policy will not participate in the nominating and governance committee's recommendation or the Board's decision regarding the resignation. The Board will then promptly and publicly disclose its decision and, if applicable, the reasons for rejecting the tendered resignation.
In the absence of instructions to the contrary, it is the intention of the persons named as proxies to vote such proxyFORthe election of the three director nominees named herein to serve as Class I directors. If any nominee should decline or be unable to serve as a director, it is intended that the proxy will be voted for the election of such person as is nominated as a replacement by the nominating and governance committee and by the Board. The Board has no reason to believe that any nominee will be unable or unwilling to serve.
Information about the Nominees and Directors
The information set forth below was furnished to us by each director or nominee and sets forth as of April 3, 2025 , the name, age, principal occupation or employment of each such person, all positions and offices such person has held with us, and the period during which he or she has served as our director or executive officer. Mr. Browning , Mr. Moriarty and Ms. Parekh have not been proposed for election, nor has any director been selected, as a director pursuant to any agreement or understanding with us or any other person.
Currently, the Board is comprised of eight members, which are divided into three classes serving staggered terms. Each director generally serves until the annual meeting of stockholders held in the third year following the year of his or her election and until a successor is duly elected and qualifies. The Bylaws provide that a majority of the entire Board may at any time increase or decrease the number of directors. However, unless the Bylaws are amended, the number of directors may never be less than the minimum required by the Maryland General Corporation Law, or more than 15.
We divide our directors into two groups-interested directors and independent directors. Independent directors are directors that the Board has affirmatively determined satisfy the requirements of Rule 303A.02 of the NYSE Listed Company Manual. Directors for which no such determination has been made are considered interested directors.
4
| Age | Position(s) Held with Company and Length of Time Served | |||||||||||||
|
|
74 | Director (Class III Director) since |
||||||||||||
|
|
61 | Director (Class II Director) and Chairman of the Board since |
||||||||||||
|
|
70 | Director (Class II Director) since |
||||||||||||
|
|
71 | Director (Class I Director) since |
||||||||||||
| 46 | Chief Executive Officer since |
|||||||||||||
|
|
64 | Director (Class I Director) since |
||||||||||||
| 46 | Director (Class I Director) since |
|||||||||||||
|
|
71 | Director (Class III Director) since |
||||||||||||
_____________________________________
* Our Board has affirmatively determined that this director is independent for purposes of the NYSE corporate governance listing requirements.
In making independence determinations, the Board reviewed information provided by the directors and by us with regard to the directors' business and personal activities as they relate to us and our affiliates, including, beneficial ownership of our common stock, and in the case of Mr. April that he is a limited partner in certain funds affiliated with Ares Management Corporation ("Ares Management"), which is the parent company of our Manager. The Board has concluded that such relationship does not impair Mr. April's independence.
Based on the recommendations of the nominating and governance committee, the Board has identified certain desired attributes for directors. Each of the directors has demonstrated high character and integrity, superior credentials and recognition in his or her respective field and the relevant expertise and experience upon which to be able to offer advice and guidance to our management. Each of the directors also has sufficient time available to devote to our affairs, is able to work with the other members of the Board and contribute to our success and can represent the long-term interests of our stockholders as a whole. The directors have been selected such that the Board represents a range of backgrounds and experience. There is no familial relationship among any of the members of the Board or executive officers.
Set forth below is biographical information for the nominees and directors as of April 3, 2025 . The biographical information of each nominee and director includes a discussion of such director's particular experience, qualifications, attributes or skills, as of the date of this proxy statement, that led the Board to conclude that such individual should serve as a director, in light of our business and structure.
5
Nominees for Class I Directors (Current term expires at this Annual Meeting)
6
and lifestyle brand, and has served in such role since 2016. Previously, she served as the Chief Operating Officer for Deepak Chopra Radical Well-Being, LLC from 2014 to 2016. Prior to that, Ms. Parekh spent ten years at Deutsche Bank Securities , focused primarily on structured credit, where she held various positions including Head of the U.S. Private Institutional Client Group and Head of Cross Product Sales. Alongside her business roles, Ms. Parekh served on the Steering Committee of the Bank's Women's Network. Ms. Parekh is also an active leader in the community serving as an Advisor to the Tufts Friedman School of Nutrition Entrepreneurship Program . She was the Co-Founder and Executive Director of the Global Foundation for Eating Disorders (GFED), a non-profit organization dedicated to funding medical research to advance cutting edge treatment in the field. She also sits on the board of severalsocial impact companies and non-profit foundations Ms. Parekh holds a Bachelor's Degree in Biological Anthropology from the University of Michigan . Ms. Parekh's significant experience in business building, strategic thinking and cultural leadership, as well as her experience in the banking and client services industries provide the Board with valuable knowledge, insight and perspective.
Directors Continuing in Office
Class II Directors (Current term expires at the 2026 Annual Meeting of Stockholders)
7
Class III Directors (Current term expires at the 2027 Annual Meeting of Stockholders)
8
obtained from his service as a chief financial officer of large organizations and his extensive knowledge in accounting, finance, capital markets, strategic planning and risk management.
The Board recommends that you vote FOR the election of William L. Browning , Edmond N. Moriarty , III and Rebecca J. Parekh as Class I directors of our Company for the term for which they have been nominated.
9
PROPOSAL 2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The audit committee and the Board have selected Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 and are submitting the selection of Ernst & Young LLP to our stockholders for ratification. Ernst & Young LLP has audited our financial statements since our inception in September 2011 through the fiscal year ended December 31, 2024 , and has also provided us certain other audit and audited-related services, from time to time. None of our Charter, Bylaws or applicable law requires stockholder ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm. However, the Board is submitting the appointment of Ernst & Young LLP to our stockholders for ratification as a matter of good corporate practice.
If our stockholders fail to ratify the selection of Ernst & Young LLP , the audit committee and the Board will consider whether or not to direct the appointment of a different independent registered public accounting firm. Even if the selection is ratified, the audit committee and the Board may direct the appointment of a different independent registered public accounting firm at any time during the year if they determine that such a change would be in our best interests.
We expect that a representative of Ernst & Young LLP will be present at the Annual Meeting, will have an opportunity to make a statement if he or she so chooses and we expect will be available to answer questions.
Principal Accountant Fees and Services
The following are aggregate fees billed to us by Ernst & Young LLP during the fiscal year ended December 31, 2024 and December 31, 2023 :
|
Fiscal Year Ended
|
Fiscal Year Ended
|
||||||||||
|
Audit Fees
|
$ | 884,800 | $ | 835,000 | |||||||
|
Audit-Related Fees
|
$ | - | $ | - | |||||||
|
Tax Fees
|
$ | - | $ | - | |||||||
|
All Other Fees
|
$ | - | $ | - | |||||||
|
Total Fees
|
$ | 884,800 | $ | 835,000 | |||||||
Audit Fees
Audit fees consist of fees billed for professional services rendered for the audit of our consolidated financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by Ernst & Young LLP in connection with statutory and regulatory filings, our registration statements and securities offerings. The increase in audit fees for 2024 as compared to 2023 was primarily attributable to cost of living adjustment and increased complexity of our investment portfolio.
Audit-Related Fees
Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under "Audit Fees." There were no audit-related fees for 2024 and 2023.
10
Tax Fees
Tax fees consist of fees billed for professional services for tax compliance, tax advice and tax planning. These services include assistance regarding federal, state and tax compliance, customs and duties, mergers and acquisitions and tax planning. There were no tax fees for 2024 and 2023.
All Other Fees
All other fees consist of fees for products and services other than the services reported above. There were no other fees for 2024 and 2023.
The audit committee, or the chairperson of the audit committee to whom such authority was delegated by the audit committee, must pre-approve all services provided by the independent registered public accounting firm. Any such pre-approval by the chairperson must be presented to the audit committee at its next regular quarterly meeting. The audit committee has also adopted policies and procedures for pre-approving certain non-prohibited work performed by our independent registered public accounting firm. Specifically, the committee has pre-approved the use of Ernst & Young LLP for specific types of services within the following categories: audit, audit-related, tax and other (if applicable). In each case, the committee has also set a specific annual limit, which can be updated, on the amount of such services which we may obtain from our independent registered public accounting firm. The audit committee does not delegate its responsibilities to pre-approve services performed by the independent registered public accounting firm to management.
The affirmative vote of at least a majority of the votes cast at the Annual Meeting is required for the approval of this proposal to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 . In the absence of instructions to the contrary, it is the intention of the persons named as proxies to vote such proxyFORthis proposal.
The Board, based on the approval and recommendation of the audit committee, recommends a vote FOR this proposal to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 .
11
PROPOSAL 3:APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS FOR THE FISCAL YEAR ENDEDDECEMBER 31, 2024
As required by Section 14A of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the Board is providing our stockholders with the opportunity to approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in accordance with SEC rules in this proxy statement. This proposal is commonly known as a "say-on-pay" proposal. At the 2019 annual meeting of stockholders, we asked our stockholders to indicate if we should hold an advisory vote on the compensation of our named executive officers every one, two or three years. At such 2019 annual meeting of stockholders, our stockholders voted in favor of an advisory vote every year. Accordingly, we again are asking our stockholders to approve the compensation of our named executive officers, this time for the fiscal year ended December 31, 2024 , as disclosed in this proxy statement in accordance with the SEC's rules. The compensation of our named executive officers as disclosed in this proxy statement includes the disclosure under "Compensation Discussion and Analysis," the compensation tables and other narrative executive compensation disclosure in this proxy statement, as required by SEC rules.
We are externally managed and advised by our Manager, a SEC registered investment adviser, pursuant to the terms of the Amended and Restated Management Agreement between us and our Manager, dated July 26, 2022 (the "Management Agreement"). We rely on our Manager to provide us with investment advisory services. Our named executive officers as described in this proxy statement are employees of our Manager or one of its affiliates and do not receive cash compensation from us for serving as our named executive officers. We do not reimburse our Manager for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of (a) our Chief Financial Officer, based on the percentage of his time spent on the Company's affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of our Manager or its affiliates who spend all or a portion of their time managing our affairs based on the percentage of their time spent on the Company's affairs. However, we do not determine the compensation payable by our Manager to Mr. Gonzales , our Chief Financial Officer, or the other personnel described above. The amounts payable to our Manager pursuant to the Management Agreement that relate to reimbursement of our Manager for the compensation paid by it to our named executive officers are described in more detail under "Compensation Discussion and Analysis" below.
In addition, our outside directors, officers, advisors, consultants, key personnel, our named executive officers, our Manager and its personnel who support our Manager in providing services to us under the Management Agreement and others who provide or are expected to provide bona fide services to us and to the other Participating Companies (as defined therein) are eligible to receive grants of incentive compensation under our Amended and Restated 2012 Equity Incentive Plan (as amended our "Equity Incentive Plan"). Please refer to "Compensation Discussion and Analysis" below for a description of grants made under our Equity Incentive Plan.
The following resolution will be presented to our stockholders at the Annual Meeting for approval on a non-binding, advisory basis:
RESOLVED, that the stockholders of the Company approve, on a non-binding, advisory basis, the compensation payable to the Company's named executive officers for the fiscal year ended December 31, 2024 , as disclosed in the Company's proxy statement for the Company's 2025 Annual Meeting of Stockholders pursuant to Securities and Exchange Commission rules, including the disclosure under "Compensation Discussion and Analysis," the compensation tables and other narrative executive compensation disclosure in the Company's proxy statement for the Company's 2025 Annual Meeting of Stockholders.
12
Although this proposal is advisory and non-binding, the Board and the compensation committee value the opinion of our stockholders and will consider the voting results when making future decisions regarding the compensation of our named executive officers.
The affirmative vote of at least a majority of the votes cast at the Annual Meeting is required for the approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024 . The persons named in the accompanying proxy intend to vote proxies received by them in favor of this proposal unless a choice of "Against" or "Abstain" is specified. Abstentions and broker non-votes will not be counted as votes cast and will have no effect on the result of the vote, although they will be considered present for determining the presence of a quorum.
The Board recommends a vote FOR the approval, on a non-binding, advisory basis, of the compensation of our named executive officers for the fiscal year ended December 31, 2024 , as disclosed in this proxy statement pursuant to Securities and Exchange Commission rules, including the disclosure under "Compensation Discussion and Analysis," the compensation tables and other narrative executive compensation disclosure in this proxy statement.
13
PROPOSAL 4:APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE FREQUENCY WITH WHICH FUTURE VOTES TO APPROVE ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS WILL BE HELD
As required by Section 14A of the Exchange Act and in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are required every six years to hold an advisory vote on the frequency of future stockholder advisory votes on the compensation of our named executive officers. Thus, we are providing our stockholders with the opportunity to vote, on a non-binding, advisory basis, on whether the Company will seek an advisory vote on the compensation of our named executive officers every one, two or three years. By voting on this proposal, stockholders will be able to specify how frequently they would like us to hold an advisory vote on the compensation of our named executive officers.This non-binding, advisory vote is commonly referred to as "say-on-pay frequency" vote.Stockholders last voted on the non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers at our annual meeting of stockholders held in 2019. At such meeting, our stockholders voted in favor of holding "say-on-pay" votes annually and the Board adopted this standard.
After careful consideration, the Board determined that future advisory votes on the compensation of our named executive officers should continue to occur every year (annually). We believe that an annual advisory vote furthers our objective of engaging in regular and timely communication with our stockholders regarding our executive compensation policies. Although this proposal is non-binding and advisory, the Board and the compensation committee value the opinion of our stockholders and will consider the voting results when making decisions regarding the frequency of future stockholder advisory votes on the compensation of our named executive officers.
With respect to the non-binding, advisory proposal on the frequency of holding future stockholder advisory votes on the compensation of our named executive officers, you may vote for "One Year," "Two Years" or "Three Years" or mark your proxy "Abstain."
The affirmative vote of at least a majority of the votes cast at the Annual Meeting is required for the selection, on a non-binding, advisory basis, of the frequency with which non-binding, advisory votes on the compensation of the Company's named executive officers will be held. However, if none of the frequency alternatives ("One Year," "Two Years" or "Three Years") receive a majority of the votes cast, we will consider the frequency with the highest number of votes cast by stockholders to be the frequency that has been selected by our stockholders. The persons named in the accompanying proxy intend to vote proxies received by them in favor of "One Year" unless a choice "One Year," "Two Years" or "Abstain" is specified. Abstentions and broker non-votes will not be counted as votes cast and will have no effect on the result of the vote, although they will be considered present for determining the presence of a quorum.
The Board recommends that a non-binding, advisory vote to approve the compensation of the Company's named executive officers be held every ONE YEAR.
14
Notwithstanding anything to the contrary set forth in any of the Company's previous filings under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, that might incorporate future filings, including this proxy statement, in whole or in part, the following Report of the Audit Committee shall not be deemed to be "soliciting material" or to be "filed" with the Securities and Exchange Commission , nor shall such information be incorporated by reference into any such filings under the Securities Act or the Exchange Act.
REPORT OF THE AUDIT COMMITTEE
The primary role of the audit committee (the "Audit Committee") of the board of directors (the "Board") of Ares Commercial Real Estate Corporation (the "Company") is to assist the Board in its oversight of, among other things, the integrity of the Company's financial statements, the Company's compliance with legal and regulatory requirements, the qualifications and independence of any independent registered public accounting firm engaged by the Company, and the performance of the Company's internal audit function and any independent registered public accounting firm. However, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company's financial statements are complete and accurate, fairly present the information shown or are in accordance with generally accepted accounting principles in the United States of America ("GAAP") and applicable rules and regulations. Nor is it the duty of the Audit Committee to conduct investigations or to assure compliance with any law, regulation or rule of the New York Stock Exchange ("NYSE"), or the Company's Corporate Governance Guidelines or Code of Business Conduct and Ethics. The Company's management is responsible for the preparation, presentation and integrity of its financial statements, for its accounting and financial reporting principles and for the establishment and effectiveness of internal controls and procedures designed to assure compliance with accounting standards and applicable laws and regulations.
The independent registered public accounting firm is responsible for performing an independent audit of the Company's financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States ) and expressing an opinion as to the conformity of such financial statements with GAAP and for auditing and reporting on the effectiveness of the Company's internal control over financial reporting.
The directors that serve on the Audit Committee have reviewed and discussed the Company's audited financial statements for the fiscal year ended December 31, 2024 with management and with Ernst & Young LLP , the Company's independent registered public accounting firm. The Audit Committee has discussed with Ernst & Young LLP the matters required to be discussed under the applicable requirements of the Public Company Accounting Oversight Board and the Securities and Exchange Commission , including Auditing Standard No. 1301,Communications with Audit Committees, as currently in effect.
The Audit Committee assists the Board in appointing our independent registered public accounting firm, Ernst & Young LLP , which includes, among other things, reviewing and evaluating the performance of the lead audit partner responsible for our audit, overseeing the required rotation of the lead audit partner and reviewing and considering the selection of the lead audit partner. In appointing Ernst & Young LLP and the lead audit partner, the Audit Committee considered, among other things, the quality and efficiency of the services provided, including Ernst & Young LLP's performance, the technical capabilities of the engagement teams, external data concerning Ernst & Young LLP's audit quality and performance obtained from reports of the Public Company Accounting Oversight Board and the engagement teams' understanding of our Company's business. The Audit Committee and the Board believe that the continued retention of Ernst & Young LLP to serve as the Company's independent registered public accounting firm is in the best interests of the Company and its stockholders and have recommended that stockholders ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 .
15
Further, the Audit Committee has (1) received from Ernst & Young LLP the written disclosures and the letter required by applicable requirements of the Public Company Accounting Oversight Board Rule 3526,Communication with Audit Committees Concerning Independence, regarding the independent registered public accounting firm's communications with the Audit Committee concerning independence, (2) discussed with the independent registered public accounting firm its independence and (3) considered, among other things, the audit and non-audit services performed by, and the amount of fees paid for such services to, the independent registered public accounting firm.
The Board has determined that each member of the Audit Committee is independent for purposes of the NYSE Listed Company Manual and Rule 10A-3 under the Exchange Act. The Board has also determined that each member of the Audit Committee is financially literate as required by the NYSE Listed Company Manual, and that each of William L. Browning , Edmond N. Moriarty , III and James E. Skinner has the accounting or related financial management expertise required by the NYSE Listed Company Manual, and is an "audit committee financial expert" within the meaning of the rules and regulations of the Securities and Exchange Commission .
Based on the review and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements for the fiscal year ended December 31, 2024 be included in the Company's Annual Report on Form 10-K for such year for filing with the SEC . In addition, the Audit Committee approved, and recommended to the Board that it approve, Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 and that the selection of Ernst & Young LLP be submitted to the Company's stockholders for ratification.
|
The Audit Committee
|
|||||
16
CORPORATE GOVERNANCE-BOARD OF DIRECTORS AND COMMITTEES
Board Leadership Structure
Our business is managed by our Manager, subject to the supervision and oversight of the Board. A majority of the Board is "independent," as determined by the requirements of the NYSE Listed Company Manual and the rules and regulations of the SEC . Our Board has the responsibility for establishing broad corporate policies and for our overall performance and direction, but is not involved in our day-to-day operations. Our directors keep informed about our business by attending meetings of the Board and its committees and through supplemental reports and communications with our Manager and our executive officers. Our non-management directors meet regularly in an executive session without the presence of our officers or management directors to review, among other matters, the performance of our Chief Executive Officer and senior management. In addition, our non-management directors will meet in executive session at other times at the request of any non-management director. Our independent directors also meet in executive session at least once a year in compliance with NYSE Listed Company Manual. Our Lead Independent Director, Caroline E. Blakely , acts as the presiding independent director and presides at meetings of the independent directors or non-management directors.
The Board monitors and performs an oversight role with respect to our business and affairs, including with respect to investment practices and performance, compliance with regulatory requirements and the services, expenses and performance of certain of our service providers. Among other things, the Board elects our officers and either directly or by delegation to the audit committee or compensation committee reviews and monitors the services and activities performed by our Manager and our officers.
The Board has designated Caroline E. Blakely , one of our independent directors, to serve as Lead Independent Director. The Lead Independent Director serves as the liaison between management and the independent directors. The Lead Independent Director's duties include facilitating communication with the Board, presiding over regularly conducted executive sessions of the independent directors and calling meetings of the independent directors. It is the role of the Lead Independent Director to review matters such as the Board meeting agendas and, where appropriate, other information provided to the directors, the allocation of sufficient time for discussion, and the number and frequency of Board meetings; however, all directors are encouraged to, and in fact do, consult with management on each of the above topics. The Lead Independent Director and each of the other directors communicate routinely with the Chairman of the Board and our Chief Executive Officer who is also a director, as appropriate, regarding appropriate agenda topics and other matters related to the Board. The Board believes that a Lead Independent Director with the ability to call meetings of independent directors when necessary improves the independence of the Board's leadership structure and its role in risk oversight, as discussed further below under "Board Role in Risk Oversight".
Under the Bylaws, the Board may designate a Chair to preside over the meetings of the Board and meetings of the stockholders and to perform such other duties as may be assigned to him or her by the Board. We do not have a fixed policy as to whether the Chair of the Board should be an independent director and we believe that our flexibility to select our Chair and reorganize our leadership structure from time to time is in the best interests of our Company and our stockholders.
Presently, Mr. Benjamin serves as the Chairman of the Board. We believe that we are best served through our existing leadership structure with Mr. Benjamin serving as a non-executive Chairman of the Board combined with Ms. Blakely serving as Lead Independent Director. We believe that Mr. Benjamin's familiarity with the Ares platform, including as Co-Head of Ares Real Estate , and depth of experience as a senior real estate executive qualifies him to serve as the Chairman of the Board, and his relationship with Ares provides an effective bridge between the Board and our Manager, thus ensuring an open dialogue between the Board and our Manager and that both groups act with a common purpose.
The Board has formed an audit committee, a nominating and governance committee and a compensation committee and has adopted charters for each of these committees which are available on our website atwww.arescre.com. The audit
17
committee currently has three directors, the compensation committee currently has three directors and the nominating and governance committee currently has three directors. Each of these committees is composed exclusively of independent directors, as defined by the NYSE Listed Company Manual and the rules of the SEC .
The Board has the exclusive power to amend our Bylaws. Our Bylaws primarily address matters such as quorums for board, committee and stockholders meetings; stock certificates; inspectors of election; corporate seals; checks, drafts and deposits; written consents of directors and committees as well as advance notice of stockholder nominations and proposals; stockholder-requested special meeting procedures; and indemnification and expense advancement for directors and officers.Our Board has considered our corporate governance policies, including our Board's exclusive power to amend our Bylaws, and considered feedback received from our stockholders and the voting results at our annual meetings of stockholders.We believe that the Board is best suited to address the matters covered by our Bylaws because under Maryland law each director has legal duties to our Company, access to more information (including the views of other directors) than any single stockholder or group of stockholders and the legitimacy of having been elected by the stockholders. Most importantly, Maryland law requires each director to act with a reasonable belief that his or her action is in the best interests of our Company as a continuing entity rather than in the interest of the stockholders, who are a constantly changing group and none of whom has any duty to our Company.
We believe that the leadership structure of our Board must be evaluated from time to time and that our existing Board leadership structure provides sufficient independent oversight over our Manager. In addition, we believe that the current governance structure, including the office of the Lead Independent Director and a Board made up of a majority of independent directors, strikes an appropriate balance between strong and consistent leadership and independent oversight of our business and affairs. However, we re-examine our corporate governance policies on an ongoing basis to ensure that they continue to meet our needs.
Board's Role in Risk Oversight
The Board performs its risk oversight function and fulfills its risk oversight responsibilities primarily through the audit committee, which reports to the entire Board and is comprised solely of independent directors. The audit committee, with input from our Manager and our General Counsel, discusses and reviews our guidelines and policies, as applicable, with respect to risk assessment and risk management, including our major financial risk exposures, enterprise risk-management, including corporate sustainability and cybersecurity, data privacy and related regulatory risks and other risk exposures relevant to our computerized information system controls and security, and the steps management has taken to monitor and control such exposures. With respect to cybersecurity, certain members of the Ares Management Enterprise Risk Committee periodically report to our audit committee as well as our full Board, as appropriate, on cybersecurity matters. During 2024, our audit committee discussed with our Manager and its personnel on Ares Management's strategy with respect to the use of artificial intelligence, including risk controls relating to this technology. In addition, the audit committee's risk oversight responsibilities include overseeing: (1) the integrity of our financial statements; (2) our compliance with legal and regulatory requirements; (3) the qualifications and independence of any independent registered public accounting firm engaged by us; and (4) the performance of our internal audit function and our independent registered public accounting firm.
In addition, the Board and the audit committee meet regularly with our Manager and consider the feedback our Manager provides concerning the risks related to our enterprise, business, operations and strategies. Our Manager regularly reports to the Board and the audit committee on our investment portfolio and the risks related thereto, asset impairments, leverage position, affiliate payments (including payments made and expenses reimbursed pursuant to the terms of the Management Agreement), compliance with applicable covenants under the agreements governing our indebtedness, compliance with our qualification as a real estate investment trust for U.S. federal income tax purposes, or "REIT," and compliance with our exemption from registration under the Investment Company Act of 1940, as amended. Members of the Board are routinely in contact with our Manager and our executive officers, as appropriate, in connection with their consideration of matters submitted for the approval of the Board or the audit committee and the risks associated with such
18
matters. As described below in more detail under "Nominating and Governance Committee" and "Compensation Committee," the nominating and governance committee and compensation committee also assist the Board in fulfilling its risk oversight responsibilities.
We believe that the extent of the Board's (and its committees') role in risk oversight complements the Board's leadership structure because it allows our independent directors, through the three fully independent Board committees, executive sessions with the independent auditors, and otherwise, to exercise oversight of risk without any conflict that might discourage critical review.
We believe that a board of directors' role in risk oversight must be evaluated on a case by case basis and that the Board's role in risk oversight is appropriate. However, we re-examine the manner in which the Board administers its oversight function on an ongoing basis to ensure that it continues to meet our needs.
Number of Meetings of the Board and Attendance in 2024
During 2024, the Board held seven formal meetings, the audit committee held seven formal meetings, the nominating and governance committee held four formal meetings and the compensation committee held six formal meetings. Each director then in office attended at least 75% of the meetings of the Board and of the meetings of the committees of the Board on which such director served. We expect each director serving on the Board to regularly attend meetings of the Board and the committees on which such director serves, and to review, prior to meetings, materials distributed in advance for such meetings. A director who is unable to attend a meeting is expected to notify the Chairman of the Board or the chairperson of the appropriate committee in advance of such meeting. We encourage, but do not require, the directors to attend our annual meetings of stockholders. All directors attended our 2024 annual meeting of stockholders.
Audit Committee
The members of the audit committee during 2024 and the current members of the audit committee are Messrs. Browning, Moriarty and Skinner, each of whom is independent for purposes of the NYSE corporate governance listing requirements and rules and regulations of the SEC . Mr. Browning currently serves as Chairperson of the audit committee.
The audit committee is responsible for the appointment, compensation, retention and oversight of the work of our independent accountants, reviewing with our independent accountants the plan and results of the audit engagement, approving professional services provided by our independent accountants, reviewing the independence of our independent accountants and reviewing the adequacy of our internal accounting controls. During meetings of the audit committee, members of the audit committee, our independent accountants and other attendees, including members of management, discussed and reviewed, among other matters, the following: our SEC filings, including our annual audited and quarterly unaudited financial statements, our critical accounting policies and practices, the financial reporting process, management's assessment of the effectiveness of our internal control over financial reporting, the effect of regulatory and accounting initiatives on our financial statements and ESG risks. In addition, the audit committee discussed with management our major financial risk exposures and enterprise risk management, including our cybersecurity, data privacy, related regulatory risks and other risk exposures relevant to our computerized information system controls and security, including Ares Management's strategy with respect to the use of artificial intelligence, and the steps management has taken to monitor and control such exposures, including our risk assessment and risk management policies. The specific responsibilities of the audit committee are set forth in its written charter, which is available for viewing on our website atwww.arescre.com.
The Board has determined that each of Messrs. Browning, Moriarty and Skinner has the accounting or related financial management expertise required by the NYSE Listed Company Manual, and is an "audit committee financial expert"
19
within the meaning of the rules and regulations of the SEC . In addition, the Board has determined that all of the members of the audit committee are financially literate as required by the NYSE Listed Company Manual.
Nominating and Governance Committee
The members of the nominating and governance committee during 2024 and the current members of the nominating and governance committee are Mr. April , Mr. Moriarty and Ms. Parekh , each of whom is independent for purposes of the NYSE corporate governance listing requirements and rules and regulations of the SEC . Mr. April currently serves as Chairperson of the nominating and governance committee.
The nominating and governance committee's responsibilities include identifying individuals qualified to become Board members (consistent with the criteria approved by the Board) and recommending for selection by the Board the director nominees to stand for election at each annual meeting of our stockholders, recommending to the Board director nominees for each committee of the Board, developing and recommending to the Board a set of corporate governance guidelines and recommending to the Board such other matters of corporate governance as the nominating and governance committee deems appropriate. The nominating and governance committee reviews the independence of Board members and director nominees and monitors all other activities that could interfere with such individuals' duties to us.In addition, the nominating and governance committee annually facilitates the assessment of our Board's performance as a whole, including its committees, and that of the individual directors and reports thereon to our Board.The specific responsibilities of the nominating and governance committee are set forth in its written charter, which is available for viewing on our website atwww.arescre.com.
In considering possible candidates for election as a director, the nominating and governance committee takes into account, in addition to such other factors as it deems relevant, the desirability of selecting directors who:
• are of high character and integrity;
• are accomplished in their respective fields, with superior credentials and recognition;
• have relevant expertise and experience upon which to be able to offer advice and guidance to management;
• have sufficient time available to devote to our affairs;
• are able to work with the other members of the Board and contribute to our success;
• can represent the long-term interests of our stockholders as a whole; and
• are selected such that the Board represents a diverse range of backgrounds and experience.
The Board is committed to a policy of inclusiveness and to pursuing diversity in terms of background and perspective. As such, when evaluating candidates for nomination as new directors, the nominating and governance committee seeks to consider candidates with diverse backgrounds in terms of knowledge, experience, skills, and other characteristics. Further, the nominating and governance committee remains committed to ensuring that individuals evaluated for future vacancies reflect a broad mix of backgrounds and experience.
The nominating and governance committee considers recommendations of candidates for membership on the Board from management, directors and stockholders. Recommendations by stockholders must be sent in writing to our principal executive offices. The nominating and governance committee and the Board will evaluate candidates recommended by stockholders in the same manner in which it evaluates other nominees. The nominating and governance committee may consider nomination of directors from our stockholders (as contrasted with recommendations of potential nominees).
20
Nominations made by stockholders must be delivered to or mailed (setting forth the information required by the Bylaws) and received at our principal executive offices not earlier than the 150th day nor later than 5:00 p.m. , EasteTime, on the 120th day prior to the first anniversary of the date on which we first mailed our proxy materials for the previous year's annual meeting of stockholders; provided, however, that if the date of the annual meeting has changed by more than 30 days from the prior year, the nomination must be received no earlier than the 150th day prior to the date of such annual meeting nor later than 5:00 p.m. , EasteTime, on the later of (1) the 120th day prior to the date of such annual meeting or (2) the 10th day following the day on which public announcement of such meeting date is first made.
Compensation Committee
The members of the compensation committee during 2024 and the current members of the compensation committee are Messrs. April, Browning and Skinner, each of whom is independent for purposes of the NYSE corporate governance listing requirements and rules and regulations of the SEC , including the compensation committee requirements of NYSE Rule 303A.05 and Rule 303A.02(a)(ii). Mr. Skinner currently serves as Chairperson of the compensation committee.
The compensation committee is responsible for overseeing plans and programs related to the compensation of our Manager, including reviewing the performance of and compensation payable to the Manager pursuant to the Management Agreement, administering and implementing our Equity Incentive Plan, reviewing and recommending the adoption, amendment or modification of a clawback policy, and preparing reports on or relating to executive compensation required by the rules and regulations of the SEC . The compensation committee, with input from its compensation consultant and our Manager, discusses and considers potential risks that arise from our compensation practices, policies and programs. The compensation committee may, in its discretion, delegate all or a portion of its duties and responsibilities to a sub-committee, independent director, or committee comprised of independent directors, to the extent permitted by applicable laws, regulations, and NYSE rules. The specific responsibilities of the compensation committee are set forth in its written charter, which is available for viewing on our website atwww.arescre.com.
Communications with the Board of Directors
The Board welcomes communications from our stockholders and other interested parties. Stockholders and other interested parties may send communications to the Board, to the non-management or independent directors as a group or to any particular director, to the following address: c/o Ares Commercial Real Estate Corporation , 245 Park Avenue , 42nd Floor, New York, NY 10167. Stockholders should indicate clearly the director or directors to whom the communication is being sent so that each communication may be forwarded directly to the appropriate director or group of directors. Any such communications may be made anonymously. Unsolicited advertisements, invitations to conferences or promotional materials, in the discretion of our Secretary, are not required, however, to be forwarded to the directors.
Code of Business Conduct and Ethics
The Board adopted a Code of Business Conduct and Ethics that applies to our directors, officers and employees. Among other matters, our Code of Business Conduct and Ethics is designed to deter wrongdoing and to promote:
• honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
• full, fair, accurate, timely and understandable disclosure in our SEC reports and other public communications;
• compliance with applicable governmental laws, rules and regulations;
21
• prompt internal reporting of violations of the code to appropriate persons identified in the code; and
• accountability for adherence to the code.
Any waiver of the Code of Business Conduct and Ethics for our executive officers or directors may be made only by the Board and will be promptly disclosed as required by law or stock exchange regulations on our website atir.arescre.com. Waivers to the Code of Business Conduct and Ethics can be obtained from the audit committee or another committee comprised of independent directors designated by the Board to serve such function. The Code of Business Conduct and Ethics can be accessed via our website atwww.arescre.com.
Corporate Governance Guidelines (including Director Majority Vote Resignation Policy)
The Board has adopted Corporate Governance Guidelines that address significant issues of corporate governance and set forth procedures by which the Board carries out certain of its responsibilities. Among the areas addressed by the Corporate Governance Guidelines are the composition of the Board, roles and standards of conduct of directors, director qualification standards and the nomination process, outside directorships, the role of the Lead Independent Director, access to management and independent advisors, director compensation, director orientation and continuing education, management succession, the annual performance evaluation and review of the Board and its committees and our director majority vote resignation policy. For a description of our director majority vote resignation policy, see the section of this proxy statement entitled "Proposal 1: Election of Directors." Our Corporate Governance Guidelines do not prohibit directors from serving simultaneously on multiple companies' boards but require that, if a director serves on four or more public company boards simultaneously, including our Board, a determination is made by our Board as to whether such simultaneous service impairs the ability of such member to effectively serve our Company. In addition, under our audit committee charter, our Board must determine that the simultaneous service of an audit committee member on the audit committees of more than three public companies would not impair such member's ability to effectively serve on our audit committee. Independent directors must advise the Chairman of the Board and the chairperson of the nominating committee in advance of accepting an invitation to serve on another board. Service on other boards and/or committees also must be consistent with the Company's conflict of interest policies set forth in the Corporate Governance Guidelines. Directors who are also employees of an Ares Management party are expected to resign from the Board at the same time they leave employment or materially change their position with an Ares Management party. The Corporate Governance Guidelines can be accessed via our website atwww.arescre.com.
Insider Trading Policy
The Board has adopted an Insider Trading Policy ("Policy") governing the purchase, sale and other dispositions of the Company's securities by directors, officers and employees of the Company or the Manager that is designed to promote compliance with insider trading laws, rules, and regulations, as well as applicable listing standards. In addition, with regard to the Company's trading in its own securities, it is the Company's policy to comply with all applicable insider trading laws, rules and regulations as well as applicable listing standards. A copy of the Policy was filed as Exhibit 19.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 .
Hedging and Speculative Trading
The Board has adopted, as part of our Policy, prohibitions against our executive officers and directors and any director, officer or employee of our Manager engaging in transactions of a speculative nature involving our securities, including, but not limited to, buying or selling puts or calls or other derivative securities based on our securities without prior approval of the Manager's Chief Compliance Officer or another designated member. In addition, such persons are prohibited from short-selling our securities or entering into hedging or monetization transactions or similar arrangements with respect to our securities (other than securities granted under our Equity Incentive Plan) without prior approval.
22
Pledging of Company Securities
The Board has adopted, as part of our Policy, prohibitions against our executive officers and directors and any director, officer or employee of our Manager holding the Company's securities in a margin account or pledging the Company's securities as collateral for a loan without prior approval of the Manager's Chief Compliance Officer or another designated member.
Stock Ownership Guidelines
To align the interests of our directors and executive officers with those of our stockholders, the Board expects our directors and certain of our executive officers to own significant equity in our Company. Accordingly, we have adopted stock ownership guidelines (the "Stock Ownership Guidelines") requiring (1) each director to achieve an equity ownership level in the Company equal to three times the annual cash fees received by the independent directors for serving on the Board and (2) our Chief Executive Officer and Chief Financial Officer to maintain ownership of at least 100,000 and 32,000 shares of our common stock, respectively. Restricted common stock awards and restricted stock units, including unvested restricted stock granted in respect of annual director fees or otherwise are counted toward achieving the Stock Ownership Guidelines. Directors have a three-year grace period and our Chief Executive Officer and Chief Financial Officer have a six-year grace period to comply with the Stock Ownership Guidelines, commencing on the date of the election as a director or appointment or promotion as an executive officer, as applicable. In the event of any increase to the directors' annual cash fees, the directors will have a one-year grace period from the time of the increase to acquire any additional equity needed to meet the Stock Ownership Guidelines. If, at the end of the applicable grace period, any director or executive officer does not achieve the requisite equity ownership level, we will require such director or executive officer to hold all vested awards of equity, other than awards withheld or sold to pay withholding taxes, until the required ownership level has been satisfied. Additionally, the nominating and governance committee reserves the right to provide exceptions for extenuating personal circumstances on a case-by-case basis. As of the date of this proxy statement, all directors and executive officers have met or are on track to meet the requirements of the Stock Ownership Guidelines, subject to any applicable grace periods.
Our Manager is a subsidiary of Ares Management , a publicly traded, leading global alternative asset manager. Ares Management has adopted a Responsible Investment Program and works collaboratively with its various underwriting, asset management, legal and compliance teams to appropriately integrate relevant environmental, social and governance considerations into the investment process.
23
(iii) employee health and wellness, (iv) workplace flexibility and (v) philanthropy. As of December 31, 2024 , Ares Management had over 3,200 employees, operating across North America , Europe , Asia Pacific and the Middle East . Of those employees, over 295 were investment professionals within Ares Management's real estate team.
Composition of our Board of Directors
As of March 26, 2025 , two directors identified as female and one director identified as a racial/ethnic minority.
Stockholder Outreach and Engagement
We believe that effective corporate governance includes regular and constructive communication with our stockholders to understand their perspectives and answer their inquiries. Throughout the year, we engage with a significant portion of our stockholders, including our top institutional investors. Through these outreach efforts, we discuss a variety of topics of interest to our stockholders, including, among other things, our financial performance, strategy and corporate governance policies and practices.
At the 2024 annual meeting of stockholders held on May 22, 2024 , a large majority of our stockholders that casted votes at the annual meeting with respect to the proposal, voted in favor of the proposal to elect each of Mr. April , Mr. Skinner and Mr. Donohoe as Class III directors to serve until our 2027 annual meeting of stockholders and until their successors are duly elected and qualify. In connection with the proposal, we engaged in stockholder outreach regarding our corporate governance policies and practices.
We reexamine our corporate governance policies on an ongoing basis to ensure that they continue to meet our needs. This examination includes discussion of, among other matters, our corporate policies, committee charters, rights of our stockholders, provisions of our Charter and Bylaws and provisions of Maryland law that are applicable to us. As a result of such reexamination and in consideration of the feedback received from our stockholders, over the past few years we have implemented the following changes:
•We adopted Stock Ownership Guidelines applicable to our directors and our Chief Executive Officer and Chief Financial Officer;
•We adopted, as part of our insider trading policy, restrictions on the use of margin accounts, pledging, hedging and speculative trading with respect to Company securities;
•We adopted a director majority vote policy as part of our Corporate Governance Guidelines;
•Caroline E. Blakely continues to serve as our Lead Independent Director;
•Since the appointment of an additional independent director to the Board in 2021, 75% of our Board is comprised of independent directors;
•We amended our Bylaws to enhance certain procedural requirements for the submission of stockholder nominees as a result of the effectiveness of Rule 14a-19 under the Exchange Act; and
•We adopted a clawback policythat complies with NYSE's clawback rules promulgated under Section 10D of the Exchange Act and the rules promulgated thereunder.
24
COMPENSATION OF DIRECTORS
Our independent directors receive an annual fee of $175,000 , payable approximately 54% in shares of restricted common stock and approximately 46% in cash. The awards of restricted common stock in respect of annual fees, which are granted pursuant to our Equity Incentive Plan, vest ratably on a quarterly basis over a one-year period. The lead independent director receives an additional annual fee of $25,000 in cash. The chairperson of the audit committee receives an additional annual fee of $20,000 in cash, and the chairperson of each of the nominating and governance committee and compensation committee receives an additional annual fee of $10,000 in cash for his or her additional services in these capacities. In addition, each audit committee member, other than the chairperson, receives an additional annual fee of $10,000 in cash, and each member of the nominating and governance committee and compensation committee (other than the chairperson of such committees) receives an additional annual fee of $5,000 in cash for his or her services in these capacities. Each of our directors is also entitled to reimbursement of reasonable out of pocket expenses incurred in connection with attending each Board meeting and each committee meeting. Each of our directors who were outside directors at the time of joining the Board received an initial grant of 5,000 restricted shares of our common stock in connection with joining the Board.
The following table shows information regarding the compensation received by our independent directors for the fiscal year ended December 31, 2024 .
|
Fees Earned
or Paid in Cash ($)(1) |
Restricted Stock
Awards ($)(2)(3) |
Total ($) | ||||||||||||||||||
|
|
$ | 95,000 | $ | 95,000 | $ | 190,000 | ||||||||||||||
|
|
$ | 105,000 | $ | 95,000 | $ | 200,000 | ||||||||||||||
|
|
$ | 105,000 | $ | 95,000 | $ | 200,000 | ||||||||||||||
|
|
$ | 95,000 | $ | 95,000 | $ | 190,000 | ||||||||||||||
|
|
$ | 100,000 | $ | 95,000 | $ | 195,000 | ||||||||||||||
|
|
$ | 85,000 | $ | 95,000 | $ | 180,000 | ||||||||||||||
___________________________________
(1) Amounts in this column represent the total annual Board and committee fees paid to independent directors in 2024.
(2) Amounts in this column represent the aggregate grant date fair value of awards of restricted stock calculated in accordance with FASB ASC Topic 718. The grant date fair values of awards have been determined based on the assumptions and methodologies set forth in Note 10 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 .
(3) As of December 31, 2024 , the following directors had the following amounts of shares of outstanding unvested restricted common stock: Mr. April , 6,920, Ms. Blakely , 6,920, Mr. Browning , 6,920, Mr. Moriarty , 6,920, Ms. Parekh , 7,337, and Mr. Skinner , 6,920.
25
EXECUTIVE OFFICERS
Set forth below is biographical information for each of our executive officers as of April 3, 2025 . The information set forth below was furnished to us by each named executive officer. No executive officer has been selected as an executive officer pursuant to any agreement or understanding with us or any other person.
| Age | Position(s) Held with Company and Length of Time Served | |||||||||||||
|
|
46 | Chief Executive Officer since |
||||||||||||
|
|
57 | Chief Operating Officer since |
||||||||||||
| 40 | Chief Financial Officer and Treasurer since |
|||||||||||||
|
|
58 | President since |
||||||||||||
|
|
44 | Vice President and Secretary since |
||||||||||||
26
EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
Overview
We are externally managed and advised by our Manager pursuant to the Management Agreement. For details regarding payments under the Management Agreement, see "Certain Relationships and Related Transactions-Management Agreement."
Each of our named executive officers is an employee of our Manager or one of its affiliates. We rely completely on our Manager to provide us with investment advisory services and our Manager manages our day to day operations. As highlighted in the table below, we do not provide cash compensation to any of our named executive officers or other officers.
Instead, we pay our Manager a base management fee and an incentive fee and we reimburse our Manager for our allocable share of the salaries and other compensation paid by the Manager or its affiliates to our (a) Chief Financial Officer, based on the percentage of his time spent on our affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of our Manager or its affiliates who spend all or a portion of their time managing our affairs based on the percentage of their time spent on our affairs. We have reported the compensation that we reimburse to our Manager for our named executive officers in "Summary Compensation Table" set forth below.
|
Highlights of our Management Agreement and Compensation Structure
• Base Management Fee-Our Manager receives a management fee equal to 1.5% of our stockholders' equity, subject to certain adjustments, which is used, in part, to pay the compensation of our Manager's employees, with no specific portion allocated to our named executive officers. For 2024, the management fees were approximately
• Incentive Fee-Our Manager is eligible for performance-based fees if our Core Earnings (as defined in the Management Agreement) exceed certain thresholds set forth in the Management Agreement with our Manager. For fiscal year 2024, no incentive fees were incurred.
• Role of our Named Executive Officers-All of our named executive officers are employees of our Manager or one of its affiliates and are engaged in additional capacities for our Manager and its affiliates. Our Manager is responsible for the compensation of our named executive officers and other employees of our Manager who support the services our Manager provides to us. We do not determine the compensation payable by our Manager to our Chief Executive Officer, Chief Financial Officer or the other personnel described above. See "Compensation of our Named Executive Officers by
|
||
Compensation of our Named Executive Officers by Ares Management
Our Manager is a subsidiary of Ares Management , a publicly traded, leading global alternative asset manager. As of December 31, 2024 , Ares Management had more than 3,200 employees operating across North America , Europe , Asia Pacific and the Middle East . Since its inception in 1997, Ares Management has adhered to a disciplined investment philosophy that focuses on delivering strong risk-adjusted investment returns throughout market cycles. Ares Management believes its distinct but complementary investment groups in Real Assets, which manages comprehensive equity and debt strategies across real estate and infrastructure investments, as well as Credit, Private Equity and Secondaries is a market
27
leader based on assets under management and investment performance. Ares Management was built upon the fundamental principle that each group benefits from being part of the greater whole.
•Performance-Based Compensation:Establish a clear relationship between performance and compensation;
•Alignment:Align the interests of key employees with fund investors and unitholders to maximize value; and
•Competitive Pay:Provide competitive incentive opportunities, with an appropriate balance between short-term and long-term incentives.
•Base salaries:Dictated by employee proficiency and experience in their roles. In addition to base salary, Ares Management utilizes a blend of variable and long-term pay vehicles to further incentivize and retain talent and provide an overall compensation package that is competitive with the market.
•Performance-Based discretionary bonuses:Generally paid annually to employees based on Ares Management's profitability, market analysis and employee performance. Select senior professionals may also receive carried interest or incentive fee participation. Our Manager and its affiliates take into account our performance as a factor in determining the compensation of certain of our named executive officers. For example, to the extent that our Manager earns additional incentive fees under the Management Agreement in the future, certain of our named executive officers may be eligible to receive a portion of such incentive fee.
•Equity grants:Ares Management's grants equity to incentivize its key employees' continued employment and to align the interests of management with fund investors and unitholders, including grants of restricted units.
Each of our named executive officers is an employee of our Manager or one of its affiliates. Our Manager uses the proceeds from the management fee, in part, to pay the compensation of our named executive officers and other employees of our Manager who support the services our Manager provides to us. Except for the grants of time-vested restricted stock units ("RSUs") described in "-2024 Equity Grants" below, we did not pay any compensation of any kind to our named executive officers during the fiscal year ended December 31, 2024 . We have reported the compensation that we reimbursed to our Manager for our named executive officers in the table set forth below. Other than these reimbursed amounts, our Manager and its affiliates cannot segregate and identify that portion of the compensation awarded to, earned by or paid to each of our named executive officers that relates exclusively to their services to us, as all of our named executive officers are engaged in additional capacities for our Manager and its affiliates. As such, the compensation of our named executive officers reflects their various roles with our Manager and its affiliates. Decisions with respect to our named executive officers' compensation are made based on the compensation policy of Ares Management described above rather than a specific formula to calculate the fixed and variable or incentive pay portion of our named executive officers' compensation.
In order to provide stockholders with additional context in which to consider our named executive officers' compensation in relation to our management fee and incentive fee, we provide an estimate of aggregate compensation of our named executive officers paid by Ares Management and its affiliates that may reasonably be associated with the company
28
based on the approximate percentage of each of their time spent on our affairs during fiscal year 2024. Applying such methodology to the compensation of our named executive officers for 2024, the total compensation paid by Ares Management and its affiliates to our named executive officers reasonably associated with their management of our company is approximately $1.1 million . Of this compensation, approximately 74% was fixed compensation and 26% was variable or incentive compensation. See "Certain Relationships and Related Transactions-Management Agreement," for more detail regarding the management fee and incentive fee paid pursuant to the Management Agreement.
Equity Compensation
The Board has delegated its administrative responsibilities under our Equity Incentive Plan to the compensation committee. The charter of the compensation committee provides that it shall approve all awards granted under the Equity Incentive Plan. Pursuant to our Equity Incentive Plan, the compensation committee may, from time to time, grant awards consisting of restricted shares of our common stock, restricted stock units and/or other equity-based awards to qualified directors, officers, advisors, consultants and other personnel, including the named executive officers. The compensation committee's objectives in developing and administering equity-based awards are to create incentives to improve long-term stock price performance and focus on long-term business objectives, create substantial retention incentives for award recipients and enhance our ability to pay compensation based on our overall performance, each of which further align the interests of the awardees with our stockholders. The equity-based awards are generally subject to time-based vesting requirements designed to achieve strong performance for our Company. When issuing equity-based awards, the compensation committee considers the value and terms of such awards in light of the level of risk that was taken to generate those returns to ensure that compensation decisions neither encourage nor reward excessive or inappropriate risk taking. Further the compensation committee seeks to support a culture committed to paying for performance where compensation is commensurate with the level of performance achieved while maintaining flexibility and discretion to allow us to recognize the unique characteristics of our operations and strategy, and our prevailing business environment, as well as changing employment market dynamics. While the compensation committee implements and approves all awards granted under our Equity Incentive Plan related to our named executive officers and approves recommendations related to incentive compensation for our other employees, the compensation committee seeks and considers the advice and counsel of Mr. Benjamin , our Chairman, given his familiarity with Ares Management's compensation philosophy as Co-Head of Ares Real Estate .
The compensation committee will, on an ongoing basis, continue to examine and assess our executive compensation practices relative to our compensation philosophy and objectives, as well as competitive market practices, and will make or recommend to our Board modifications to the compensation programs, as deemed appropriate.
Compensation Consultant
The compensation committee engaged Ferguson Partners Consulting, L.P. ("FPC") as its independent compensation consultant to assist the compensation committee in developing and evaluating the framework for issuing long-term equity-based awards to our named executive officers and other personnel of our Manager. At the time of FPC's engagement, the compensation committee reviewed FPC's independence and determined that FPC's work for the compensation committee did not raise any conflict of interest pursuant to the SEC and NYSE rules. FPC met with the compensation committee on several occasions in 2024 to discuss guiding principles, industry pay practices, compensation strategy and other compensation considerations.
2024 Equity Grants
In December 2024 , we granted 45,000, 17,000, 25,000 and 32,500 RSUs under our Equity Incentive Plan to Messrs. Donohoe, Feingold, Gonzales, and Yoon, respectively. The RSUs issued in December 2024 are scheduled to vest ratably on an annual basis over a three-year period, beginning on January 1, 2026 , generally subject to the named executive officer's
29
continued service through the applicable vesting date. In determining each of these equity-based awards for 2024, the compensation committee did not apply any fixed metrics. Rather, the compensation committee took into consideration a range of factors, including financial performance such as the performance of our common stock and our retuon equity, as well as operational performance such as our investment activity, management of our financing facilities, our operations, policies and practices, as well as the performance of each of our named executive officers.
RSUs represent a right to receive shares of our common stock, subject to satisfaction of the applicable vesting condition(s), with such shares of common stock to be delivered upon or as soon as reasonably practicable following the applicable vesting date. In addition, to the extent that ordinary cash dividends are paid to holders of shares of our common stock, outstanding RSUs are entitled to a corresponding dividend equivalent payment.
Section 280G of the Internal Revenue Code
Section 280G of the Code disallows a tax deduction with respect to "excess parachute payments" to certain executive officers of companies that undergo a change in control. In addition, Section 4999 of the Code imposes a 20% excise tax penalty on the individual receiving the "excess parachute payment." Parachute payments are compensation that is linked to or triggered by a change in control and may include, but are not limited to, bonus payments, severance payments, certain fringe benefits, and payments and acceleration of vesting from long-term incentive plans or programs and other equity-based compensation. "Excess parachute payments" are parachute payments that excess a threshold determined under Section 280G of the Internal Revenue Code based on an executive officer's prior compensation. In approving compensation arrangements for our named executive officers, the Manager, the Board and the compensation committee, as applicable, consider all elements of the cost to us of providing such compensation, including the potential impact of Section 280G of the Code. However, the Board may, in its judgment, authorize compensation arrangements that could give rise to loss of deductibility of Section 280G of the Code and the imposition of excise taxes under Section 4999 of the Code when it believes that such arrangements are appropriate to attract and retain executive talent. We do not provide for excise tax gross-ups to our executive officers and do not expect to do so in the future.
Section 162(m) Compliance
Section 162(m) of the Internal Revenue Code limits us to a deduction for federal income tax purposes of no more than $1 million of compensation paid to certain executive officers in a taxable year.
Section 409A Considerations
Section 409A of the Code, affects the manner by which deferred compensation opportunities are offered to our named executive officers because Section 409A requires, among other things, that "non-qualified deferred compensation" be structured in a manner that limits employees' abilities to accelerate or further defer certain kinds of deferred compensation. We intend to operate our existing compensation arrangements that are covered by Section 409A in accordance with the applicable rules thereunder, and we will continue to review and amend our compensation arrangements where necessary to comply with Section 409A.
Say on Pay Vote
At our annual meeting of stockholders during 2024, we provided our stockholders with the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of the named executive officers for the fiscal year ended December 31, 2023 . A substantial majority of the votes casted (approximately 90%) on this matter at that annual meeting of stockholders approved the compensation of the named executive officers as described in our proxy statement for our annual meeting of stockholders during 2024. The Board and compensation committee reviewed the results of this non-binding, advisory "say on pay" vote and considered the results supportive of our compensation policies and decisions. A non-binding,
30
advisory vote on the frequency of "say on pay" votes will also be held at our Annual Meeting this year. Our Board is recommending that stockholders select "ONE YEAR" with respect to such vote.
Clawback Policy
On October 31, 2023 , the Board adopted a Clawback Policy that complies with NYSE's clawback rules promulgated under Section 10D of the Exchange Act and the rules promulgated thereunder. If we are required to prepare an accounting restatement of our financial statements due to our material noncompliance with any such financial reporting requirement, the Board will require reimbursement or forfeiture of the Overpayment (as defined below) received by any covered executive from the Company during the three completed fiscal years immediately preceding the date on which we are required to prepare the restatement and any transition period (that results from a change in the Company's fiscal year) within or immediately following those three completed fiscal years. Executives covered by the clawback policy are current and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act, the rules promulgated thereunder, and the NYSE listing standards. Incentive-based compensation is defined as any compensation that is granted to, earned by, or received by, a covered executive, based wholly or in part upon the attainment of a financial reporting measure. The amount subject to recovery is the amount of incentive-based compensation received from the Company that is in excess of the amount of incentive-based compensation that otherwise would have been received from the Company had the incentive-based compensation been determined based on the restated financial statements, and must be computed without regard to any taxes paid ("Overpayment"). The Clawback Policy only applies to incentive-based compensation received on or after the date the Clawback Policy was adopted by the Board.
31
Notwithstanding anything to the contrary set forth in any of the Company's previous filings under the Securities Act or the Exchange Act that might incorporate future filings, including this proxy statement, in whole or in part, the following Compensation Committee Report shall not be deemed to be "soliciting material" or to be "filed" with the SEC , nor shall such information be incorporated by reference into any such filings under the Securities Act or the Exchange Act.
COMPENSATION COMMITTEE REPORT
The compensation committee (the "Compensation Committee") of the board of directors (the "Board") of Ares Commercial Real Estate Corporation (the "Company") is responsible for administering the Company's Equity Incentive Plan and overseeing the performance of Ares Commercial Real Estate Management LLC (the "Manager") and the management fees and other compensation payable to the Manager pursuant to the Amended and Restated Management Agreement between the Company and the Manager dated July 26, 2022 . The directors that serve on the Compensation Committee have reviewed and discussed with management the "Compensation Discussion and Analysis" included in this proxy statement. Based on that review and discussion, the Compensation Committee recommended to the Board that the "Compensation Discussion and Analysis" be included in this proxy statement.
|
The Compensation Committee
|
|||||
32
2024 Summary Compensation Table
The following table shows the amounts reimbursed to our Manager with respect to the annual compensation received by the named executive officers for the fiscal years ended December 31, 2022 , 2023 and 2024 that were allocable to us, except that no disclosure is provided for any named executive officer, other than our principal executive officer and principal financial officer, whose total compensation did not exceed $100,000 . No other executive officers are included as named executive officers in the table below because we did not reimburse our Manager for any amounts in excess of $100,000 with respect to any compensation received by any other executive officer for the fiscal year ended December 31, 2024 . As noted elsewhere herein, the named executive officers do not receive any direct cash compensation from us. See "-Compensation of our Executive Officers by Ares Management " above.
| Year | Salary ($) | Bonus ($) |
StockAwards ($)(1)
|
All Other Compensation ($) |
Total ($) | ||||||||||||||||||||||||||||||||||||
|
|
2024 | - | - | 287,550 | - | 287,550 | |||||||||||||||||||||||||||||||||||
|
Chief Executive Officer
|
2023 | - | - | 637,200 | - | 637,200 | |||||||||||||||||||||||||||||||||||
| 2022 | - | - | 686,080 | - | 686,080 | ||||||||||||||||||||||||||||||||||||
|
|
2024 | 197,678 | 90,932 | 207,675 | - | 496,285 | |||||||||||||||||||||||||||||||||||
|
Chief Operating Officer and Former Chief Financial Officer and Treasurer
|
2023 | 125,609 | 57,780 | 432,000 | - | 615,389 | |||||||||||||||||||||||||||||||||||
| 2022 | 129,666 | 68,723 | 428,800 | - | 627,189 | ||||||||||||||||||||||||||||||||||||
|
|
2024 | 189,526 | 131,807 | 159,750 | - | 481,083 | |||||||||||||||||||||||||||||||||||
| Chief Financial Officer and Treasurer | |||||||||||||||||||||||||||||||||||||||||
|
|
2024 | 128,846 | 92,033 | 108,630 | - | 329,509 | |||||||||||||||||||||||||||||||||||
|
General Counsel, Vice President and Secretary
|
2023 | 90,373 | 81,901 | 226,800 | - | 399,074 | |||||||||||||||||||||||||||||||||||
| 2022 | 117,083 | 101,899 | 209,040 | - | 428,022 | ||||||||||||||||||||||||||||||||||||
___________________________________
(1) Amounts in this column represent the aggregate grant date fair value of awards of restricted shares of common stock and RSUs computed in accordance with FASB Accounting Standards Codification ("ASC") Topic 718. The grant date fair values of awards have been determined based on the assumptions and methodologies set forth in Note 10 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 .
(2) Amounts in the columns entitled "Salary" and "Bonus" represent the allocable share of the compensation, including annual base salary and discretionary bonus, which we reimbursed to our Manager.
33
2024 Grants of Plan-Based Awards
The following table summarizes certain information regarding plan-based awards granted during the 2024 fiscal year to our named executive officers.
| Grant Date |
Date of
Board Action
|
All Other Stock
Awards: Number of
Shares of Stock or
Units (#)
|
Grant Date Fair
Value of Stock and
Option Awards ($)(2)
|
|||||||||||||||||||||||
|
|
45,000 | (1) | $ | 287,550 | ||||||||||||||||||||||
|
|
32,500 | (1) | $ | 207,675 | ||||||||||||||||||||||
| 25,000 | (1) | $ | 159,750 | |||||||||||||||||||||||
|
|
17,000 | (1) | $ | 108,630 | ||||||||||||||||||||||
____________________________________
(1) The RSUs vest in three equal annual installments on each of January 1, 2026 , 2027 and 2028.
(2) The amount in this column represents the aggregate grant date fair value of the award granted in 2024 computed in accordance with FASB ASC Topic 718.
2024 Outstanding Equity Awards at Fiscal Year End
The following table summarizes certain information regarding equity-incentive plan awards outstanding as of the end of the 2024 fiscal year to the named executive officers. The market value of the shares in the following table is the fair value of such shares on December 31, 2024 .
| Stock Awards | ||||||||||||||
|
Number of Shares or Units of
Stock That Have Not Vested (#)(1) |
Market Value of Shares or Units of Stock That Have Not Vested ($)(2)
|
|||||||||||||
|
|
164,166 | $ | 966,938 | |||||||||||
|
|
109,166 | $ | 642,988 | |||||||||||
| 46,166 | $ | 271,918 | ||||||||||||
|
|
55,500 | $ | 326,895 | |||||||||||
______________________________
(1) The amounts in this column represent the following grants of RSUs pursuant to our Equity Incentive Plan granted to our named executive officers that were outstanding as of December 31, 2024 . For more information on the RSUs, see "Compensation Discussion and Analysis-Equity Compensation" and "Compensation Discussion and Analysis-2024 Equity Grants."
a.Mr. Donohoe : 17,500 RSUs granted on December 21, 2021 that vested on January 1, 2025 ; 42,666 RSUs granted on December 20, 2022 , one-half of which vested on January 1, 2025 and the remaining one-half of which vests on January 1, 2026 ; 59,000 RSUs granted on December 20, 2023 , one-third of which vested on January 1, 2025 , and the remaining two-third of which vest ratably on January 1, 2026 and January 1, 2027 ; and 45,000 RSUs granted on December 20, 2024 that vest in three equal annual installments on each of January 1, 2026 , 2027 and 2028.
b.Mr. Yoon : 10,000 RSUs granted on December 21, 2021 that vested on January 1, 2025 ; 26,666 RSUs granted on December 20, 2022 , one-half of which vested on January 1, 2025 and the remaining one-half of which vests on January 1, 2026 ; 40,000 RSUs granted on December 20, 2023 , one-third of which vested on January 1, 2025 , and the remaining two-third of which vest ratably on January 1, 2026 and January 1, 2027 ; and 32,500 RSU's granted on December 20, 2024 that vest in three equal annual installments on each of January 1, 2026 , 2027 and 2028.
c.Mr. Gonzales : 2,166 RSUs granted on December 21, 2021 that vested on January 1, 2025 ; 6,000 RSUs granted on December 20, 2022 , one-half of which vested on January 1, 2025 and the remaining one-half of which vests on January 1, 2026 ; 13,000 RSUs granted on December 20, 2023 ,
34
one-third of which vested on January 1, 2025 , and the remaining two-third of which vest ratably on January 1, 2026 and January 1, 2027 ; and 25,000 RSUs granted on December 20, 2024 that vest is three equal annual installments on each of January 1, 2026 , 2027 and 2028.
d.Mr. Feingold : 4,500 RSUs granted December 21, 2021 that vested on January 1, 2025 ; 13,000 RSU granted on December 20, 2022 , one-half of which vested on January 1, 2025 and the remaining one-half of which vests on January 1, 2026 ; 21,000 RSUs granted on December 20, 2023 , one-third of which vested on January 1, 2025 , and the remaining two-third of which vest ratably on January 1, 2026 and January 1, 2027 ; and 17,000 RSUs granted on December 20, 2024 that vest in three equal annual installments on each of January 1, 2026 , 2027 and 2028.
(2) Based on the closing price of our common stock on the last business day of the fiscal year ended December 31, 2024 of $5.89 .
2024 Option Exercises and Stock Vested
No stock options have been granted by us to date. The following table summarizes certain information regarding awards of RSUs that vested during the 2024 fiscal year with respect to the named executive officers.
| Stock Awards | ||||||||||||||
|
Number of Shares Acquired on Vesting (#)(1)
|
Value Realized
on Vesting ($)(2) |
|||||||||||||
|
|
49,500 | $ | 511,540 | |||||||||||
|
|
31,667 | $ | 329,803 | |||||||||||
| 6,250 | $ | 64,620 | ||||||||||||
|
|
14,500 | $ | 149,800 | |||||||||||
______________________________
(1) Represents the gross number of shares acquired on vesting of RSUs, without taking into account any shares withheld to satisfy applicable tax obligations.
(2) The Value Realized on Vesting column reflects the aggregate value realized with respect to all RSUs that vested in fiscal year 2024. The value realized in connection with each vesting of RSUs is calculated as the number of vested RSUs multiplied by the closing price of our common stock on the vesting date.
Retirement Benefits
The named executive officers received no benefits in the 2024 fiscal year from us under defined pension or defined contribution plans.
Nonqualified Deferred Compensation
We do not have a nonqualified deferred compensation plan that provides for deferral of compensation on a basis that is not tax-qualified for the named executive officers.
Potential Payments Upon Termination or Change in Control
The named executive officers are employees of our Manager or its affiliates and therefore we generally have no obligation to pay them any form of compensation upon their termination of employment, except with respect to any RSU award agreement entered into between us and such named executive officer. Other than as noted below, these agreements provide that any unvested portion of the award shall be immediately and irrevocably forfeited and cancelled for no consideration upon a termination of employment. Upon a Change in Control (as defined in our Equity Incentive Plan), the compensation committee may make such adjustments as it, in its discretion, determines are necessary or appropriate in light of the Change in Control, but only if the compensation committee determines that such adjustments do not have a substantial adverse economic impact on the participants (as determined at the time of the adjustments). The RSUs granted to the named executive officers will fully vest if (i) such named executive officer incurs a termination of service due to death or disability
35
or (ii) there is a Change of Manager Event (as defined in the RSU award agreement) prior to the termination of such named executive officer's service. If the Company terminates such named executive officer's services due to his termination of employment with Ares Operations LLC (an affiliate of our Manager which employs the named executive officers) without Cause (as defined in the RSU award agreement), the portion of such RSUs that would have vested during the 12 months following such termination will vest.
The following table sets forth information on the potential value of the accelerated RSUs to the named executive officers upon certain terminations or upon a change in control, assuming such termination or change in control occurred on December 31, 2024 :
|
Acceleration of Equity Vesting ($)(1)
|
||||||||||||||||||||
| Donohoe | Yoon | Gonzales | Feingold | |||||||||||||||||
| Termination due to termination of employment with |
$ | 344,565 | $ | 215,970 | $ | 55,955 | $ | 106,020 | ||||||||||||
| Termination due to Death or Disability | $ | 966,940 | $ | 642,990 | $ | 271,920 | $ | 326,895 | ||||||||||||
| Termination in connection with a Change in Manager Event | $ | 966,940 | $ | 642,990 | $ | 271,920 | $ | 326,895 | ||||||||||||
___________________________
(1)Reflects the value of the acceleration of the named executive officer's RSUs, determined based on the closing price of a share of our common stock on December 31, 2024 (the last trading day of the fiscal year), which was $5.89 .
Pay Versus Performance
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid (as defined by SEC Rules) and certain financial performance of the Company. We do not use any financial performance measures to link compensation actually paid to our named executive officers to the Company's performance. Accordingly, pursuant to SEC rules, we have not included a "Company-Selected Measure" or a tabular list of performance measures. For more information about our executive compensation program, please refer to the "Executive Compensation-Compensation Discussion and Analysis" above.
|
Summary Compensation Table Total for PEO(1)
|
Compensation Actually Paid to PEO(2)
|
Average Summary Compensation Table Total for Non-PEO NEOs(3)
|
Average Compensation Actually Paid to Non-PEO NEOs(4)
|
Total Shareholder Return(5)
|
Peer Group Total Shareholder Return(6)
|
Net Income (Loss) | ||||||||||||||||||||||||||||||||||||||
| Year | ($) | ($) | ($) | ($) | ($) | ($) | ($ in thousands) | |||||||||||||||||||||||||||||||||||||
| 2024 | 287,550 | (123,868) | 435,626 | 274,403 | 70.69 | 45.31 | (34,993) | |||||||||||||||||||||||||||||||||||||
| 2023 | 637,200 | 795,446 | 507,232 | 575,017 | 107.35 | 51.23 | (38,867) | |||||||||||||||||||||||||||||||||||||
| 2022 | 686,080 | 425,295 | 527,606 | 429,903 | 92.97 | 50.39 | 29,785 | |||||||||||||||||||||||||||||||||||||
| 2021 | 760,200 | 996,739 | 521,349 | 661,164 | 116.63 | 77.73 | 60,460 | |||||||||||||||||||||||||||||||||||||
| 2020 | 629,625 | 880,553 | 619,994 | 485,604 | 86.85 | 72.33 | 21,840 | |||||||||||||||||||||||||||||||||||||
36
___________________________________
(1) The dollar amounts reported in this column are the amounts of total compensation reported for our Chief Executive Officer (the "PEO") for each corresponding year, as reported in the "Total" column of the Summary Compensation Table. The name of the PEO of the Company reflected in these columns for each of the applicable fiscal years is Bryan P. Donohoe .
(2) "Compensation Actually Paid" has been calculated in accordance with the requirements of Item 402(v)(2)(iii) of Regulation S-K and does not reflect compensation actually earned, realized or received. The following adjustments in the table below were made to the amounts reported for Mr. Donohoe in the Summary Compensation Table. In calculating "Compensation Actually Paid", the fair value or change in fair value, as applicable, of the equity award adjustments included in each calculation was computed in accordance with FASB ASC Topic 718. Importantly, the dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. Donohoe during the applicable year.
| 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||||||||||||||
| Description | ($) | ($) | ($) | ($) | ($) | ||||||||||||||||||||||||
| Reported Summary Compensation Total for PEO | 629,625 | 760,200 | 686,080 | 637,200 | 287,550 | ||||||||||||||||||||||||
|
Change in Pension Value Deduction for PEO(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Pension Service Cost Addition for PEO(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Prior Pension Service Cost Addition for PEO(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Reported Stock Awards Deduction for PEO(b)
|
(629,625) | (760,200) | (686,080) | (637,200) | (287,550) | ||||||||||||||||||||||||
|
Equity Award Adjustments for PEO(c)
|
880,553 | 996,739 | 425,295 | 795,446 | (123,868) | ||||||||||||||||||||||||
| Compensation Actually Paid to PEO | 880,553 | 996,739 | 425,295 | 795,446 | (123,868) | ||||||||||||||||||||||||
____________________________________
(a) The Company has no pension plans.
(b) Total grant date fair value of equity awards reported in the "Stock Awards" column in the Summary Compensation Table for the applicable year. Mr. Donohoe did not receive option awards in the years shown.
(c) For each covered year, the amounts added or deducted in calculated equity award adjustments include:
| Year End |
Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards for PEO | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year for PEO | Year over Year Change in Fair Value of Equity Awards Granted in |
Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year for PEO | Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation for PEO | Total Equity Award Adjustments for PEO | ||||||||||||||||||||||||||||||||||||||
| Year | ($) | ($) | ($) | ($) | ($) | ($) | ($) | |||||||||||||||||||||||||||||||||||||
| 2024 | 265,050 | (532,672) | - | (1,280) | - | 145,034 | (123,868) | |||||||||||||||||||||||||||||||||||||
| 2023 | 611,240 | 7,677 | - | 10,927 | - | 165,602 | 795,446 | |||||||||||||||||||||||||||||||||||||
| 2022 | 658,560 | (367,268) | - | 4,883 | - | 129,120 | 425,295 | |||||||||||||||||||||||||||||||||||||
| 2021 | 763,350 | 150,347 | - | - | - | 83,042 | 996,739 | |||||||||||||||||||||||||||||||||||||
| 2020 | 830,723 | - | - | - | - | 49,830 | 880,553 | |||||||||||||||||||||||||||||||||||||
37
____________________________________
(3) The dollar amounts reported in this column represent the average of the total amounts reported for our non-PEO named executive officers (the "Other NEOs") for each corresponding year in the "Total" column of the Summary Compensation Table. For each of the applicable fiscal years, our Other NEOs were Tae-Sik Yoon and Anton S. Feingold .
(4) "Compensation Actually Paid" has been calculated in accordance with the requirements of Item 402(v)(2)(iii) of Regulation S-K and does not reflect compensation actually earned, realized or received. When calculating the "average compensation actually paid for the Other NEOs, the following adjustments in the table below were made to the amounts reported in the Summary Compensation Table. In calculating "Compensation Actually Paid", the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. Importantly, the dollar amounts do not reflect the actual amount of compensation earned by or paid to our Other NEOs as a group during the applicable year.
| 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||||||||||||||
| Description | ($) | ($) | ($) | ($) | ($) | ||||||||||||||||||||||||
| Average Reported Summary Compensation Total for Other NEOs | 619,994 | 521,349 | 527,606 | 507,232 | 435,626 | ||||||||||||||||||||||||
|
Average Change in Pension Value Deduction for Other NEOs(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Average Pension Service Cost Addition for Other NEOs(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Average Prior Pension Service Cost Addition for Other NEOs(a)
|
- | - | - | - | - | ||||||||||||||||||||||||
|
Average Reported Stock Awards Deduction for Other NEOs(b)
|
(274,938) | (314,940) | (318,920) | (329,400) | (158,685) | ||||||||||||||||||||||||
|
Average Equity Award Adjustments for Other NEOs(c)
|
140,548 | 454,755 | 221,217 | 397,185 | (2,538) | ||||||||||||||||||||||||
| Average Compensation Actually Paid to Other NEOs | 485,604 | 661,164 | 429,903 | 575,017 | 274,403 | ||||||||||||||||||||||||
____________________________________
(a) The Company has no pension plans.
(b) Average total grant date fair value of equity awards reported in the "Stock Awards" column in the Summary Compensation Table for the applicable year. The Other NEOs did not receive option awards in the years shown.
(c) For each covered year, the amounts added or deducted in calculated equity award adjustments include:
| Year End |
Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards for Other NEOs | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year for Other NEOs | Year over Year Change in Fair Value of Equity Awards Granted in |
Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year for Other NEOs | Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation for Other NEOs | Total Equity Award Adjustments for Other NEOs | ||||||||||||||||||||||||||||||||||||||
| Year | ($) | ($) | ($) | ($) | ($) | ($) | ($) | |||||||||||||||||||||||||||||||||||||
| 2024 | 146,268 | (203,134) | - | (517) | - | 54,845 | (2,538) | |||||||||||||||||||||||||||||||||||||
| 2023 | 315,980 | 3,511 | - | 3,397 | - | 74,297 | 397,185 | |||||||||||||||||||||||||||||||||||||
| 2022 | 306,128 | (148,299) | - | 8,122 | - | 55,266 | 221,217 | |||||||||||||||||||||||||||||||||||||
| 2021 | 316,245 | 68,172 | - | 25,568 | - | 44,770 | 454,755 | |||||||||||||||||||||||||||||||||||||
| 2020 | 258,239 | (61,905) | - | (90,040) | - | 34,254 | 140,548 | |||||||||||||||||||||||||||||||||||||
38
____________________________________
(5) The total shareholder retuas calculated based on a fixed investment of one hundred ($100) dollars measured from the market close on December 31, 2019 (the last trading day of 2019) through and including the end of the fiscal year for each year reported in the table.
(6) Total shareholder retufor our peer group is the FTSE NAREIT All Mortgage Capped Index (the "Peer Group "), which we also use for purposes of the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report on Form 10-K for the year ended December 31, 2024 . We replaced the Bloomberg Mortgage REIT Index (old peer group) for 2024, following its discontinuation, with the FTSE NAREIT All Mortgage Capped Index, which we believe is representative of companies similar to ours. The information disclosed for the years 2024, 2023, 2022, 2021 and 2020 reflects the total shareholder retufor our new Peer Group . Under Item 402 of Regulation S-K, we are also required to disclose the total shareholder retuof our old peer group as filed in our definitive proxy statement filed with the SEC on April 4, 2024 .
| Total Shareholder Return | Old Peer Group Total Shareholder Retu(Bloomberg Mortgage REIT Index) | New Peer Group Total Shareholder Return (FTSE NAREIT All Mortgage Capped Index) |
|||||||||||||||||||||
| Year | ($) | ($) | ($) | ||||||||||||||||||||
| 2024 | 70.69 | N/A | 45.31 | ||||||||||||||||||||
| 2023 | 107.35 | 79.21 | 51.23 | ||||||||||||||||||||
| 2022 | 92.97 | 69.20 | 50.39 | ||||||||||||||||||||
| 2021 | 116.63 | 91.50 | 77.73 | ||||||||||||||||||||
| 2020 | 86.85 | 77.80 | 72.33 | ||||||||||||||||||||
Pay versus Performance Comparative Disclosure
As described in more detail in the section titled "Executive Compensation-Compensation Discussion and Analysis," the Company's executive compensation program reflects a variable pay-for-performance philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the table above. Further, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company's performance measures with "Compensation Actually Paid" for a particular year (as computed in accordance with Item 402(v) of Regulation S-K).
In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between the information presented in the table above.
39
Net Income
The following charts show the relationship between (1) the compensation actually paid to our PEO(s) and the average compensation actually paid to the Other NEOs (each as calculated pursuant to Item 402(v)(2)(iii) of Regulation S-K) and (2) the Company net income attributable to common stockholders ("Net Income") for the last four fiscal years.
40
Total Shareholder Return
The following charts show the relationship between (1) the compensation actually paid to our PEO and the average compensation actually paid to the Other NEOs (each as calculated pursuant to Item 402(v)(2)(iii) of Regulation S-K), (2) the cumulative total shareholder retu("TSR") of the Company for its last four completed fiscal years and (3) a comparison of the Company's Peer Group TSR for the four-year period. The Company's TSR generally outperformed the Peer Group during the four years presented in the table, representing the Company's superior financial performance as compared to the companies comprising the Peer Group .
Compensation Policies and Practices as they Relate to Risk Management
We are externally managed and advised by our Manager pursuant to the Management Agreement. Except for grants of restricted shares of common stock and RSUs described above, we did not pay any compensation of any kind to our named executive officers during the fiscal year ended December 31, 2024 . Instead, we pay our Manager a base management fee of 1.5% of our stockholders' equity per year, an incentive fee and expense reimbursements. The management fee may not be increased or revised without the approval of our independent directors. Our compensation committee is charged with overseeing plans and programs related to the compensation of our Manager, including reviewing the performance of and compensation of our Manager. See "Certain Relationships and Related Transactions-Management Agreement," for more detail regarding the management fee and incentive fee paid pursuant to the Management Agreement.
41
SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS
The following table sets forth certain information as of March 26, 2025 , the record date, regarding the ownership of our common stock by:
• each of our directors;
• each of the named executive officers;
• all of our directors and executive officers as a group;
• each person known by us to beneficially hold 5% or more of our common stock; and
• other principal shareholders.
In accordance with SEC rules, each listed person's beneficial ownership includes:
• all shares the investor actually owns beneficially or of record;
• all shares over which the investor has or shares voting or dispositive control (such as in the capacity as a general partner of an investment fund); and
• all shares the investor has the right to acquire within 60 days.
Ownership information for those persons who beneficially own 5% or more of the outstanding shares of the Company's common stock is based upon Schedule 13D, Schedule 13G or other filings by such persons with the SEC and other information obtained from such persons.
Unless otherwise indicated, all shares are owned directly, and the indicated person has sole voting and investment power. Except as indicated in the footnotes to the table below, the business address of the stockholders listed below is the address of our principal executive office, 245 Park Avenue , 42nd Floor, New York, NY 10167.
42
|
Number of Shares
of Common Stock Beneficially Owned(1) |
Percentage of
Class(2) |
|||||||||||||
|
|
||||||||||||||
|
Directors, Named Executive Officers and Nominee
|
||||||||||||||
|
|
74,552 | * | ||||||||||||
|
|
36,596 | * | ||||||||||||
|
|
66,755 | * | ||||||||||||
|
|
59,916 | * | ||||||||||||
|
|
55,330 | * | ||||||||||||
| 33,683 | * | |||||||||||||
|
|
72,642 | * | ||||||||||||
|
|
222,458 | * | ||||||||||||
|
|
78,360 | * | ||||||||||||
| 50,751 | * | |||||||||||||
| - | - | |||||||||||||
|
|
251,753 | * | ||||||||||||
|
All directors and executive officers as a group (12 persons)
|
1,002,796 | 1.8 | % | |||||||||||
|
5% or More Beneficial Owners
|
||||||||||||||
|
|
4,898,960 | 8.9 | % | |||||||||||
|
|
2,748,768 | 5.0 | % | |||||||||||
|
Other Principal Shareholders
|
||||||||||||||
|
Entities affiliated with
|
2,136,010 | 3.9 | % | |||||||||||
_________________________________
* Represents less than 1% of the shares of common stock outstanding.
(1)Amount shown includes unvested restricted shares of common stock and RSUs granted to our directors and named executive officers pursuant to our Equity Incentive Plan as of March 26, 2025 . The following unvested restricted shares and RSUs vest within 60 days of March 26, 2025 .
| Unvested Restricted Shares and RSUs |
|||||||||||
|
|
3,460 | ||||||||||
|
|
3,460 | ||||||||||
|
|
3,460 | ||||||||||
| 3,460 | |||||||||||
| 3,460 | |||||||||||
|
|
3,460 | ||||||||||
| - | |||||||||||
| - | |||||||||||
| - | |||||||||||
|
|
- | ||||||||||
_________________________________
(2)Based on 54,856,977 shares of common stock outstanding on March 26, 2025 .
(3)Includes 71,092 shares of common stock held by April Family 2013 Living Trust of which Mr. April and his spouse are the trustees.
(4)Consists of shares of common stock held by William S. Benjamin 2017 No. 1 Trust of which a family member of Mr. Benjamin is a trustee.
43
(5)Includes 59,835 shares of common stock held by The Caroline E. Blakely Living Trust of which Ms. Blakely is a trustee.
(6)Includes 46,074 shares of common stock held by The Browning Family Trust of which Mr. Browning is a trustee.
(7)On its Schedule 13G/A filed with the SEC on January 25, 2024 , BlackRock, Inc. reported sole voting power with respect to 4,793,440 shares of common stock beneficially owned by it and sole dispositive power with respect to 4,898,960 shares of common stock beneficially owned by it. The Schedule 13G/A reports a beneficial ownership percentage of shares of common stock of 9.0% based on our number of shares of common stock then outstanding, which does not include any shares acquired or sold since such percentage was calculated for the purposes of the Schedule 13G/A. The 8.9% shown above represents BlackRock, Inc.'s reported beneficially owned shares as a percentage of our number of shares outstanding as of March 26, 2024 . BlackRock, Inc.'s address is 50 Hudson Yards, New York, New York 10001.
(8)On its Schedule 13G/A filed with the SEC on February 13, 2024 , The Vanguard Group reported shared voting power with respect to 30,688 shares of common stock beneficially owned by it, sole dispositive power with respect to 2,671,948 shares of common stock beneficially owned by it and shared dispositive power with respect to 76,820 shares of common stock beneficially owned by it. The Schedule 13G/A reports a beneficial ownership percentage of shares of common stock of 5.08% based on our number of shares of common stock then outstanding, which does not include any shares acquired or sold since such percentage was calculated for the purposes of the Schedule 13G. The 5.0% shown above represents The Vanguard Group's reported beneficially owned shares as a percentage of our number of shares outstanding as of March 26, 2025 . The Vanguard Group's address is 100 Vanguard Blvd. , Malvern, PA 19355.
(9)Includes (1) 756,010 shares of common stock held by North Woodmere Capital , of which Mr. Ressler is the general partner, and (2) 1,380,000 shares of common stock held by the Ressler/Gertz Family Foundation , of which Mr. Ressler is a co-trustee and shares voting and dispositive power with his spouse and children. Mr. Ressler is the Co-Founder and Executive Chairman of Ares Management . The business address of Mr. Ressler is 2000 Avenue of the Stars , 12th Floor, Los Angeles, California 90067.
44
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
We have procedures in place for the review, approval and monitoring of transactions involving us and certain persons related to us. For example, we have a Code of Business Conduct and Ethics and Corporate Governance Guidelines that generally restrict the ability of any of our officers, directors or employees to engage in any transaction where there is a conflict between such individual's personal interest and our interests. In addition, the audit committee is required to review and pre-approve or ratify all related party transactions (as defined in Item 404 of Regulation S-K), unless such transactions are separately pre-approved by a majority of our independent directors. In determining whether to pre-approve or ratify a transaction, the members of the audit committee and our other independent directors will take into account such factors as they deem appropriate. The charter for the audit committee, Code of Business Conduct and Ethics and Corporate Governance Guidelines can be accessed via our website atwww.arescre.com.
Management Agreement
We are party to the Management Agreement, pursuant to which our Manager provides for the day-to-day management of our operations. The Management Agreement requires our Manager to manage our business affairs in conformity with the policies and the investment guidelines that may be approved and monitored by the Board. The Management Agreement has a term that expires on April 25, 2025 , and will be automatically renewed for successive one-year terms thereafter, unless terminated by either us or our Manager. Our Manager is entitled to receive a termination fee from us under certain circumstances.
Pursuant to the terms of the Management Agreement, our Manager is paid a base management fee equal to 1.5% per annum of our stockholders' equity (as defined in our Management Agreement), calculated and payable quarterly in arrears. For the fiscal year ended December 31, 2024 , we incurred approximately $10.7 million in base management fees and no incentive fees payable to our Manager pursuant to the Management Agreement.
We do not reimburse our Manager for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of our (a) Chief Financial Officer, based on the percentage of his time spent on our affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of our Manager or its affiliates who spend all or a portion of their time managing our affairs based on the percentage of their time spent on our affairs. In addition, we are required to pay our pro rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of our Manager and its affiliates required for our operations. For the fiscal year ended December 31, 2024 , we reimbursed our Manager for approximately $3.8 million , which amount represented the portion of the allocable expenses payable by us under the Management Agreement for which our Manager sought reimbursement. Ares Management , from time to time, incurs fees, costs, and expenses on behalf of more than one investment vehicle. To the extent such fees, costs, and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle will typically bear an allocable portion of any such fees, costs, and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund's governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle's governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle's allocable portion of such expense.
Our Manager is a subsidiary of Ares Management , an entity in which certain directors and officers of our Company and members of the Investment Committee of our Manager have ownership and financial interests. Our Manager and Ares Management have agreed that for so long as our Manager is managing us, neither Ares Management nor any of its affiliates will sponsor or manage any other U.S. publicly traded REIT that invests primarily in the same asset classes as us. Ares Management and its affiliates may sponsor or manage another U.S. publicly traded REIT that invests generally in real estate assets but not primarily in our target investments. Other than as described in the immediately preceding sentence, neither
45
Co-Investments with and Loan Acquisitions from other Ares Vehicles
From time to time, we may co-invest with other investment vehicles managed by Ares Management or its affiliates and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, we generally expect to act as the administrative agent for the holders of such investments provided that we maintain a majority of the aggregate investment. No fees will be received by us for performing such service. Our investment in such co-investments are generally made on a pari-passu basis with the other Ares managed investment vehicles and we are not obligated to provide, nor have we provided, any financial support to the other Ares managed investment vehicles. As such, our risk is limited to the carrying value of our investment and we recognize only the carrying value of our investment in our consolidated balance sheets.
One or more affiliates of Ares Management may originate commercial real estate loans, which may be made available to purchase by other investment vehicles, including us and other Ares Management managed investment vehicles. From time to time, we may purchase such commercial real estate loans from affiliates of Ares Management . Although our Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by our Manager in good faith to be appropriate for us, it is possible that the interests of Ares Management could be in conflict with ours and the interests of our stockholders. Our opportunity to purchase loans from Ares Management and its affiliates may be on different and potentially less favorable economic terms than other Ares managed vehicles if our Manager deems such purchase as being otherwise in our best interests. For additional detail on the purchase or co-investment of such loans see the discussion of related party transactions set forth in Note 14 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 .
Servicing Agreements
Certain of our subsidiaries, along with our lenders under certain of our secured funding facilities have entered into various servicing agreements with our Manager's servicer. Our Manager's servicer has agreed that no servicing fees pursuant to these servicing agreements would be charged to us or our subsidiaries for so long as the Management Agreement remains in effect, but that our Manager's servicer will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement.
Registration Rights Agreement
We are a party to a registration rights agreement with regard to shares held from time to time by Ares Investments Holdings LLC ("Ares Investments"), a subsidiary of Ares Management , and its affiliates, which we refer to as the registrable shares. Pursuant to the registration rights agreement, we granted Ares Investments and its direct and indirect transferees:
• unlimited demand registration rights to have the registrable shares registered for resale; and
46
• in certain circumstances, the right to "piggy-back" the registrable shares in registration statements we might file in connection with any future public offering.
Notwithstanding the foregoing, any registration is subject to cutback provisions, and we are permitted to suspend the use, from time to time, of the prospectus that is part of the registration statement (and therefore suspend sales under the registration statement) for certain periods, referred to as "blackout periods."
"Ares" License Agreement
We have entered into a license agreement with Ares Management , pursuant to which it granted us a non-exclusive, royalty-free license to use the name "Ares." Under this agreement, we have a right to use this name for so long as Ares Commercial Real Estate Management LLC remains our Manager. This license agreement may be terminated by either party without penalty upon 180 days' written notice to the other.
Director and Officer Indemnification and Liability Insurance
We purchase directors' and officers' liability insurance on behalf of our directors and officers. In addition, we have entered into indemnification agreements with each of our current directors and executive officers and intend to enter into indemnification agreements with each of our future directors and executive officers. The indemnification agreements provide these directors and executive officers the maximum indemnification permitted under Maryland law. The agreements provide, among other things, for the advancement of expenses and indemnification for liabilities which such person may incur by reason of his or her status as a present or former director of our Company in any action or proceeding arising out of the performance of such person's services as a present or former director or executive officer of our Company.
47
STOCKHOLDER NOMINATIONS AND PROPOSALS FOR THE 2026 ANNUAL MEETING
Stockholders may present proper nominations of candidates for director or other proposals for inclusion in our proxy statement and proxy card for consideration at the next annual meeting of stockholders by submitting such nominations or proposals in writing to our Secretary in a timely manner, calculated in the manner provided in Rule 14a-8(e) of the Exchange Act, applicable state law and our Charter and Bylaws.
Deadlines for Submitting Stockholder Proposals Pursuant to Rule 14a-8
To be considered timely under Rule 14a-8(e) of the Exchange Act for inclusion in our proxy statement and proxy card for a regularly scheduled annual meeting, a stockholder's proposal must be received at our principal executive offices not less than 120 calendar days before the anniversary of the date our proxy statement was released to stockholders for the previous year's annual meeting. Accordingly, a stockholder's proposal must be received no later than December 4, 2025 in order to be included in our proxy statement and proxy card for the 2026 annual meeting of stockholders. Proposals should be addressed to the General Counsel Corporate Secretary at the Company's principal executive offices, which are located at Ares Commercial Real Estate Management, 245 Park Avenue , 42nd Floor, New York, NY 10167.
Deadlines for Submitting Notice of Stockholder Proposals Under our Advance-Notice Bylaws
The deadline for submitting notice of a stockholder's nomination of a candidate for director or other proposal for consideration at the 2026 annual meeting of stockholders under the current Bylaws, is not earlier than the 150thday prior to the first anniversary of the date of release of the proxy statement for the preceding year's annual meeting nor later than 5:00 p.m. , EasteTime, on the 120thday prior to the first anniversary of the date of release of the proxy statement for the preceding year's annual meeting;provided,however, that in the event that the date of the annual meeting is advanced or delayed by more than 30 days from the anniversary of the date of the preceding year's annual meeting, notice by the stockholder to be timely must be delivered not earlier than the 150thday prior to the date of such annual meeting and not later than 5:00 p.m. , EasteTime, on the later of (1) the 120thday prior to the date of such annual meeting or (2) the tenth day following the day on which public announcement of the date of such meeting is first made. Accordingly, a stockholder's nomination of a candidate for director or other proposal must be received no earlier than November 4, 2025 and no later than 5:00 p.m. , EasteTime, on December 4, 2025 in order to be considered at the 2026 annual meeting of stockholders. In order to be considered timely, such notice shall be delivered to the Secretary at our principal executive offices at the address set forth above and shall set forth all information required under Section 11 of Article II of the Bylaws. In addition, stockholders who intend to solicit proxies in support of candidates for director, other than the Company's nominees, must also comply with any additional requirements of Rule 14a-19 under the Exchange Act.
48
ANNUAL REPORT AVAILABLE
A copy of our 2024 annual report to stockholders containing audited financial statements accompanies this proxy statement.
We will provide to each stockholder a copy (without exhibits, unless otherwise requested) of our annual report free of charge. Requests should be directed to the Investor Relations Department at Ares Commercial Real Estate Management, 245 Park Avenue , 42nd Floor, New York, NY 10167. Copies of these documents may also be accessed electronically by means of the SEC's home page on the internet at http://www.sec.gov. The annual report is not part of the proxy solicitation materials.
HOUSEHOLDING OF PROXY MATERIALS
The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement and annual report addressed to those stockholders. This process, which is commonly referred to as "householding," potentially means extra convenience for stockholders and cost savings for companies.
This year a number of brokers with account holders who are our stockholders will be "householding" their proxy materials. A single proxy statement will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. If you have received notice from your broker that it will be "householding" communications to your address, "householding" will continue until you are notified otherwise or until you revoke your consent. We will promptly deliver a separate copy of these documents to you upon written or oral request to our Investor Relations Department at Ares Commercial Real Estate Management, 245 Park Avenue , 42nd Floor, New York, NY 10167 or 888-818-5298. If, at any time, you no longer wish to participate in "householding" and would prefer to receive a separate proxy statement and annual report, please notify your broker. Stockholders who currently receive multiple copies of the proxy statement and annual report at their addresses and would like to request "householding" of their communications should contact their brokers.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May 27, 2025 :The Notice of Annual Meeting, proxy statement and the Company's 2024 annual report to stockholders are available at: http://materials.proxyvote.com/04013V.
OTHER MATTERS
The Board is not aware of any other matters to be presented at the Annual Meeting or at any adjournment or postponement thereof. Should any other matter requiring a vote of stockholders arise, it is the intention of the persons named in the proxy to vote in accordance with their discretion on such matters.
You are cordially invited to attend the Annual Meeting. Whether or not you plan to attend the virtual Annual Meeting, you are requested to promptly submit your proxy voting instructions.
| By Order of the Board of Directors, | |||||
|
/s/
|
|||||
49
Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLYTHIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. V68286-P26233 ! ! ! For All Withhold All For All Except For Against Abstain ! !! ! !! To withhold authority to vote for any individual nominee(s), mark "For All Except" and write the number(s) of the nominee(s) on the line below. ARES COMMERCIAL REAL ESTATE CORP. 245 PARK AVENUE, 42ND FLOOR NEW YORK, NY 10167 The Board of Directors recommends a vote "FOR" Proposals 2 and 3 and EVERY "ONE YEAR" with respect to Proposal 4: 01) William L. Browning 02) Edmond N. Moriarty , III 03) Rebecca J. Parekh Nominees: NOTE: The proxies are authorized to vote and otherwise represent the undersigned on such other matters as may properly come before the meeting or any adjournment or postponement thereof. 2. To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 . 3. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024 , as described in the 2025 Proxy Statement. 4. To approve, on a non-binding, advisory basis, the frequency with which future stockholder advisory votes on the compensation of the Company's named executive officers will be held. ARES COMMERCIAL REAL ESTATE CORP. The Board of Directors recommends vote "FOR" each of the director nominees below: Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Persons to serve as Class I Directors until the Company's 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualify. 1. Election of Directors 3 Years1 Year 2 Years Abstain ! !!! SCAN TO VIEW MATERIALS & VOTEw TRANSMIT VOTING INSTRUCTIONS BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. EasteTime on May 26, 2025 . Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/ACRE2025 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. TRANSMIT VOTING INSTRUCTIONS BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. EasteTime on May 26, 2025 . Have your proxy card in hand when you call and then follow the instructions. TRANSMIT VOTING INSTRUCTIONS BY MAIL Mark, sign and date your proxy card and retuit in the postage-paid envelope we have provided or retuit to Vote Processing, c/o Broadridge, 51 Mercedes Way , Edgewood, NY 11717.
V68287-P26233 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May 27, 2025 : The Notice and Proxy Statement and 2024 Annual Report are available at http://materials.proxyvote.com/04013V. ARES COMMERCIAL REAL ESTATE CORPORATION Annual Meeting of Stockholders May 27, 2025 at 1:00 PM EasteTime This proxy is solicited on behalf of the Board of Directors The undersigned hereby appoints Jeffrey Gonzales and Anton Feingold , or either one of them, and each with full power of substitution, to act as attorneys and proxies for the undersigned to attend the 2025 Annual Meeting of Stockholders of Ares Commercial Real Estate Corporation (the "Company") to cast on behalf of the undersigned all votes that the undersigned is entitled to cast at such meeting, and any adjournments or postponements thereof, and otherwise to represent the undersigned at the meeting with all powers possessed by the undersigned if personally present at the meeting. The meeting will be held via live audio webcast to enable the stockholders of the Company to participate from any location that is convenient to them. The stockholders of the Company will be able to attend the 2025 Annual Meeting of Stockholders of the Company by visiting www.virtualshareholdermeeting.com/ACRE2025 on May 27, 2025 at 1:00 p.m. , EasteTime. The undersigned acknowledges receipt from the Company prior to the execution of this proxy of a Notice of Annual Meeting of Stockholders and a Proxy Statement, the terms of which are incorporated herein by reference, and revokes any proxy heretofore given with respect to such meeting, and any adjournments or postponements thereof. THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST AS INSTRUCTED HEREIN. IF THIS PROXY IS EXECUTED BUT NO INSTRUCTION IS GIVEN, THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST "FOR" EACH OF THE NOMINEES FOR DIRECTOR IN PROPOSAL 1, "FOR" PROPOSAL 2, "FOR" PROPOSAL 3 AND EVERY "ONE YEAR" WITH RESPECT TO PROPOSAL 4. The votes entitled to be cast by the undersigned will be cast at the discretion of the proxy holder on any other matter that may properly come before the meeting or any adjournment or postponement thereof. At the present time, the Board of Directors of the Company knows of no other business to be presented at the meeting. Your vote is important. Please vote immediately. CONTINUED AND TO BE SIGNED ON REVERSE SIDE
Attachments
Disclaimer
Proxy Statement (Form DEF 14A)
Proxy Statement (Form DEF 14A)
Advisor News
- Caregiving affects ‘sandwich generation’s’ retirement plans
- Why financial consciousness is the key to long-term clarity
- Selling long-term-care insurance in a group setting
- How to overcome the fear of calling prospects
- Advisor gives students a lesson in financial reality
More Advisor NewsAnnuity News
- New Jersey becomes 50th state to adopt annuity best-interest rules
- Caregiving affects ‘sandwich generation’s’ retirement plans
- Augustar generates industry buzz with 24% premium bonus on its FIA
- Michal Wilson "Mike" Perrine
- Emerging digital annuity sales process cutting cycle times by 94%, IRI says
More Annuity NewsHealth/Employee Benefits News
- Low-income diabetes patients more likely to be uninsured
- UnitedHealth execs bemoan ‘unusual and unacceptable’ Q1 financials
- LTCi proves its value beyond peace of mind
- Governor signs ban on drug middlemen owning pharmacies
- The lighter side of The News: Political theater; A bone to pick with a Yankee; Health insurers have mascots?
More Health/Employee Benefits NewsLife Insurance News
- NAIFA eyes tax reform, retirement issues in 2025
- Legislation would change tax treatment of life insurers’ debt investments
- Closing the life insurance coverage gap by investing in education
- IUL sales: How to overcome ‘it’s too complicated’
- LIMRA: Record workplace life insurance sales up for 4th consecutive year
More Life Insurance News